DomovStrokovna javnostRaziskovalna dejavnost › Pomembnejše objave

POMEMBNEJŠE OBJAVE


2018

van Duijn Pleun Joppe, Verbrugghe Walter, Jorens Philippe Germaine, Spöhr Fabian, Schedler Dirk, Deja Maria, Rothbart Annane Djillali, Lawrence Christine, Nguyen Van Jean-Claude, Misset Benoit, Jereb Matjaz, Seme Katja, Šifrer Franc, Tomič Viktorija, Estevez Francisco, Carneiro Jandira, Harbarth Stephan, Cornelis Eijkemans Marinus Johannes, Bonten Marc, on behalf of the show SATURN consortium
The effects of antibiotic cycling and mixing on antibiotic resistance in intensive care units: a cluster-randomised crossover trial.
Lancet Infectious Diseases. Published online 24 January 2018. doi.org/10.1016/S1473-3099(18)30056-2
JRC IF (2016) = 19,864

Bahri R, Custovic A, Korosec P, Tsoumani M, Barron M, Wu J, Sayers R, Weimann A, Ruiz-Garcia M, Patel N, Robb A, Shamji MH, Fontanella S, Silar M, Mills ENC, Simpson A, Turner PJ, Bulfone-Paus S.
Mast cell activation test in the diagnosis of allergic disease and anaphylaxis.
J Allergy Clin Immunol. 2018 Mar 5. pii: S0091-6749(18)30308-7. doi: 10.1016/j.jaci.2018.01.043. [Epub ahead of print]
JRC IF (2016) = 13,081

Niederberger V, Neubauer A, Gevaert P, Zidarn M, Worm M, Aberer W, Malling HJ, faar O, Klimek L, Pfützner W, Ring J, Darsow U, Novak N, Gerth van Wijk R, Eckl-Dorna J, Focke-Tejkl M, Weber M, Müller HH, Klinger J, Stolz F, Breit N, Henning R, Valenta R.
Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32.
J Allergy Clin Immunol. 2018 Jan 11. pii: S0091-6749(17)31884-5. doi: 10.1016/j.jaci.2017.09.052.
JRC IF (2016) = 13,081

Korošec Peter, Gibbs Bernhard F., Rijavec Matija, Custovic Adnan, Turner Paul J.
Important and specific role for basophils in acute allergic reactions.
Clin Exp Allergy. 2018 Feb 12. doi: 10.1111/cea.13117. [Epub ahead of print]
JRC IF (2016) = 5,264

Grivčeva-Panovska Vesna, Košnik Mitja, Korošec Peter, Andrejević Slađana, Karadža-Lapić Ljerka, Rijavec Matija.
Hereditary angioedema due to C1-inhibitor deficiency in Macedonia: clinical characteristics, novel SERPING1 mutations, and genetic factors modifying the clinical phenotype.
Ann Med. 2018 Mar 15:1-8. doi: 10.1080/07853890.2018.1449959.
JRC IF (2016) = 3,715

Ryska A, Berzinec P, Brcic L, Cufer T, Dziadziuszko R, Gottfried M, Kovalszky I, Olszewski W, Oz B, Plank L, Timar J.
NSCLC molecular testing in Central and Eastern European countries.
BMC Cancer. 2018 Mar 9;18(1):269. doi: 10.1186/s12885-018-4023-4.
JRC IF (2016) = 3,228

Škrgat S, Korošec P, Kern I, Šilar M, Šelb J, Fležar M, Marčun R.
Systemic and airway oxidative stress in competitive swimmers
Respir Med. 2018 Apr;137:129-133. doi: 10.1016/j.rmed.2018.03.005
JRC IF (2016) = 3,217

Ariel A, Altraja A, Belevskiy A, Boros PW, Danila E, Fležar M, Koblizek V, Fridlender ZG, Kostov K, Krams A, Milenkovic B, Somfay A, Tkacova R, Tudoric N, Ulmeanu R, Valipour A
Inhaled therapies in patients with moderate COPD in clinical practice: current thinking.
International Journal of COPD. Published 21 December 2017. 2018; 13: 45-56. dx.doi.org/10.2147/COPD.S145573
JRC IF (2016) = 3,157

Rijavec M, Žavbi M, Lopert A, Fležar M, Korošec P.
GLCCI1 polymorphism rs37973 and asthma treatment response to inhaled corticosteroids.
J Investig Allergol Clin Immunol. 2018 Jan 17:0. doi: 10.18176/jiaci.0229.
JRC IF (2016) = 3,094

Brcic Luka, Vlacic Gregor, Quehenberger Franz, Kern Izidor.
Reproducibility of Malignant Pleural Mesothelioma Histopathologic Subtyping.
Arch Pathol Lab Med. 2018 Mar 6. doi: 10.5858/arpa.2017-0295-OA. [Epub ahead of print]
JRC IF (2016) = 2,981

Thunnissen E, Allen TC, Adam J, Aisner DL, Beasley MB, Borczuk AC, Cagle PT, Capelozzi VL, Cooper W, Hariri LP, Kern I, Lantuejoul S, Miller R, Mino-Kenudson M, Radonic T, Raparia K, Rekhtman N, Roy-Chowdhuri S, Russell P, Schneider F, Sholl LM, Tsao MS, Vivero M, Yatabe Y.
Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society.
Arch Pathol Lab Med. 2018;142:408–419; doi: 10.5858/ arpa.2017-0106-SA. Epub 2017 Jul 7.
JRC IF (2016) = 2,981

Dragicevic S, Kosnik M, Divac Rankov A, Rijavec M, Milosevic K, Korosec P, Skerbinjek Kavalar M, Nikolic A.
The Variants in the 3’ Untranslated Region of the Matrix Metalloproteinase 9 Gene as Modulators of Treatment Outcome in Children with Asthma.
Lung. 2018 Mar 29. doi: 10.1007/s00408-018-0113-y.
JRC IF (2016) = 1,915

Vrankar M, Zwitter M, Kern I, Stanic K.
PD-L1 expression can be regarded as prognostic factor for survival of non-small cell lung cancer patients after chemoradiotherapy.
Neoplasma. 2018;65(1):140-146. doi: 10.4149/neo_2018_170206N77.
JRC IF (2016) = 1,871


2017

Sonnenblick A, Agbor-Tarh D, Bradbury I, Di Cosimo S, Azim HA Jr, Fumagalli D ,Sarp S, Wolff AC, Andersson M, Kroep J, Cufer T, Simon SD, Salman P, Toi M, Harris L, Gralow J, Keane M, Moreno-Aspitia A, Piccart-Gebhart M, de Azambuja E
Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial.
J Clin Oncol. 2017 May 1;35(13):1421-1429. doi: 10.1200/JCO.2016.69.7722. Epub 2017 Mar 13.
JRC IF (2016) = 24,008

Jagielski T; Partnership to Fight Against TB in Central and Eastern Europe (FATE): Collaborators: Aleksa A, Bachiyska E, Bakos Á, Crudu V, Dziadek J, Homolka J, Homorodean D, Jansone I, Katalinic-Jankovic V, Krenke R, Kuzmic U, Mokrousov I, Nikolayevskyy V, Nikolenka A, Osmani GM, Papaventsis D, Pole I, Porvazník I, Savic B, Shubladze N, Solovic I, Szabó N, Tafaj S, Ustamujic A, van Ingen J, Vasiliauskiene E, Yablonsky PK, Zemanova I, Zhuravlev V, Žolnir-Dovc M.
FATE: the new partnership to Fight Against TB in Central and Eastern Europe.
Lancet Infect Dis. 2017 Apr;17(4):363. doi: 10.1016/S1473-3099(17)30120-2.
JRC IF (2016) = 19,864

Beeh KM, Burgel PR, Franssen FM, Lopez-Campos JL, Loukides S, Hurst JR, Fležar M, Ulrik CS, Di Marco F, Stolz D, Valipour A, Casserly B, Ställberg B, Kostikas K, Wedzicha JA.
How to Dual Long-Acting Bronchodilators Prevent Exacerbations of Chronic Obstructive Pulmonary Disease?
American Journal of Respiratory and Critical Care Medicine 2017, 196 (2):139–149.
JRC IF (2016) = 13.204

Brożek JL, Bousquet J, Agache I, Agarwal A, Bachert C, Bosnic-Anticevich S, Brignardello-Petersen R, Canonica GW, Casale T, Chavannes NH, Correia de Sousa J, Cruz AA, Cuello-Garcia CA, Demoly P, Dykewicz M, Etxeandia-Ikobaltzeta I, Florez ID, Fokkens W, Fonseca J, Hellings PW, Klimek L, Kowalski S, Kuna P, Laisaar KT, Larenas-Linnemann DE, Lødrup Carlsen KC, Manning PJ, Meltzer E, Mullol J, Muraro A, O'Hehir R, Ohta K, Panzner P, Papadopoulos N, Park HS, Passalacqua G, Pawankar R, Price D, Riva JJ, Roldán Y, Ryan D, Sadeghirad B, Samolinski B, Schmid-Grendelmeier P, Sheikh A, Togias A, Valero A, Valiulis A, Valovirta E, Ventresca M, Wallace D, Waserman S, Wickman M, Wiercioch W, Yepes-Nuñez JJ, Zhang L, Zhang Y, Zidarn M, Zuberbier T, Schünemann HJ.
Allergic Rhinitis and its Impact on Asthma (ARIA) Guidelines – 2016 Revision.
Journal of Allergy Clinical Immunology 2017; pii: S0091-6749(17)30919-3. doi: 10.1016/j.jaci.2017.03.050.
JRC IF (2016) = 13.081

Korosec P, Turner PJ, Silar M, Kopac P, Kosnik M, Gibbs BF, Shamji MH, Custovic A, Rijavec M.
Basophils, high-affinity IgE receptors, and CCL2 in human anaphylaxis.
Journal of Allergy Clinical Immunology; pii: S0091-6749(17)30423-2. doi: 10.1016/j.jaci.2016.12.989.
JRCIF (2016) = 13.081

Ratko Djukanović, Guy Bruselle, Samantha Walker, Stephen T. Holgate, Sabina Škrgat, Piotr Kuna, Liam G. Heaney, G. Walter Canonica and Jørgen Vestbo.
The era of research collaborations: new models of working together.
European Respiratory Journal 2017 (49), Article ID 1601848, 4 pages.
JRC IF (2016) = 10.569

S. Dhami, H. Zaman, E.‐M. Varga, G. J. Sturm, A. Muraro, C. A. Akdis, D. Antolín‐Amérigo, M. B. Bilò, D. Bokanovic, M. A. Calderon, E. Cichocka‐Jarosz, J. N. G. Oude Elberink, R. Gawlik, T. Jakob, M. Kosnik, J. Lange, E. Mingomataj, D. I. Mitsias, H. Mosbech, M. Ollert, O. Pfaar, C. Pitsios, V. Pravettoni, G. Roberts, F. Ruëff, B. A. Sin, M. Asaria, G. Netuveli and A. Sheikh.
Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis.
Allergy 2017, 72 (3): 342–365.
JRC IF (2016) = 7.361

Farkas H, Martinez-Saguer I, Bork K, Bowen T, Craig T, Frank M, Germenis AE, Grumach AS, Luczay A, Varga L, Zanichelli A; HAWK.
Collaborators (73):
Aberer W, Andrejevic S, Aygoeren-Pürsün E, Banerji A, Bara NA, Bas M, Bernstein J, Betschel S, Björkander J, Boccon-Gibod I, Bouillet L, Bova M, Boysen HH, Branco-Ferreira M, Bygum A, Caballero T, Cancian M, Castaldo A, Christiansen S, Cicardi M, Drouet C, Fabiani J, Gompels M, Gonzalez-Quevedo MT, Gooi J, Gower R, Gökmen NM, Grivcheva-Panovska V, Guilarte M, Gülbahar O, Hack E, Hakl R, Harmat G, Jeseňák M, Jolles S, Kaplan A, Katelaris C, Kosnik M, Kőhalmi KV, Leibovich I, Levi M, Li H, Longhurst HJ, Lumry W, Magerl M, Malbran A, Martin L, Maurer M, Mihály E, Moldovan D, Murdjeva M, Nagy IB, Nielsen EW, Nieto S, Nordenfelt P, Obtulowitzc K, Pedrosa M, Porębski G, Prior N, Reshef A, Riedl MA, Rosenkranz B, Schmid-Grendelmeier P, Péter S, Speletas M, Staevska M, Stobiecki M, Triggiani M, Veszeli N, Wuillemin W, Xiang ZY, Yamamoto B, Zuraw B.
International Consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency.
Allergy 2017, 72 (2):300–313.
JRC IF (2016) = 7.361

Gunter J Sturm, Eva‐Maria Varga, Graham Roberts, Holger Mosbech, M. Beatrice Bilò, Cezmi A Akdis, Darío Antolín‐Amérigo, Ewa Cichocka‐Jarosz, Radoslaw Gawlik, Thilo Jakob, Mitja Kosnik, Joanna Lange, Ervin Mingomataj, Dimitris I Mitsias, Markus Ollert, Joanna N.G. Oude Elberink, Oliver Pfaar, Constantinos Pitsios, Valerio Pravettoni, Franziska Ruëff, Betül Ayşe Sin, Ioana Agache, Elizabeth Angier, Stefania Arasi, Moises A Calderón, Montserrat Fernandez‐Rivas, Susanne Halken, Marek Jutel, Susanne Lau, Giovanni B Pajno, Ronald van Ree, Dermot Ryan, Otto Spranger, Roy Gerth van Wijk, Sangeeta Dhami, Hadar Zaman, Aziz Sheikh and Antonella Muraro.
EAACI Guidelines on Allergen Immunotherapy: Hymenoptera venom allergy.
Allergy 2017, DOI: 10.1111/all.13262
JRC IF (2016) = 7.361

Hellings PW, Fokkens WJ, Bachert C, Akdis CA, Bieber T, Agache I, Bernal-Sprekelsen M, Canonica GW, Gevaert P, Joos G, Lund V, Muraro A, Onerci M, Zuberbier T, Pugin B, Seys SF, Bousquet J; ARIA and EPOS working groups - ARIA and EPOS working groups - Collaborators (338): Aberer W, Agache I, Akdis CA, Akdis M, Alobid I, Ankri J, Annesi-Maesano I, Ansotegui IJ, Anto JM, Arnavielhe S, Arshad H, Asarnoj A, Avolio F, Bachert C, Bachert C, Baiardini I, Barbagallo M, Barbara C, Baroody F, Bateman ED, Bedbrook A, Beghé B, Bel EH, Bennoor KS, Benson M, Bergmann KC, Bewick M, Bialoszewski AZ, Bieber T, Bindslev-Jensen C, Bjermer L, Blain H, Blasi F, Boner AL, Bonini M, Bonini S, Bosnic-Anticevich S, Bosse I, Bouchard J, Boulet LP, Bourret R, Bousquet J, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Brozek J, Bucca C, Buhl R, Bunu C, Burte E, Bush A, Caballero-Fonseca F, Caimmi DP, Calderon MA, Camargos PA, Camuzat T, Canonica GW, Cardona V, Carlsen KH, Carr W, Carreiro-Martins P, Carriazo AM, Casale T, Cepeda Sarabia AM, Cervin A, Cesari M, Chatzi L, Chavannes NH, Chiron R, Chivato T, Chkhartishvili E, Chuchalin AG, Chung KF, Ciprandi G, Cohen N, Conzález Diaz S, Cox L, Crooks G, Cruz AA, Custovic A, Dahl R, Dahlen SE, Darsow U, De Carlo G, De Manuel Keenoy E, de Sousa JC, De Vries G, Dedeu T, Deleanu D, Demoly P, Denburg JA, Devillier P, Didier A, Dinh-Xuan AT, Dokic D, Douagui H, Douglas R, Dray G, Du Toit G, Dubakiene R, Durham SR, Dykewicz MS, Eklund P, El-Gamal Y, Ellers E, Emuzyte R, Farrell J, Fink Wagner A, Fiocchi A, Fletcher M, Fokkens WJ, Fonseca J, Forastiere F, Gaga M, Gamkrelidze A, Gemicioğlu B, Georgalas C, Gereda JE, Gevaert P, Goossens H, Grisle I, Guldemond NA, Gutter Z, Guzmán MA, Haahtela T, Harvey R, Heinrich J, Hellings PW, Hellings PW, Hellquist-Dahl B, Hopkins C, Horak F, Hourihane JO, Humbert M, Hyland M, Iaccarino G, Illario M, Jares EJ, Jeandel C, Johnston SL, Jonquet O, Joos G, Joos G, Jung KS, Just J, Jutel M, Kaidashev I, Kalayci O, Kalogjera L, Kalyoncu AF, Kardas P, Keil T, Keith PK, Kerkhof M, Kern B, Kerstjens HA, Khaitov M, Khaltaev N, Klimek L, Kogevinas M, Kolek V, Koppelman GH, Kowalski M, Kowalski ML, Kuitunen M, Kull I, Kuna P, Kvedariene V, Lambrecht B, Larenas-Linnemann D, Lau S, Laune D, Le LT, Li J, Lieberman P, Lipworth B, Lodrup Carlsen KC, Louis R, Lund VJ, Lupinek C, MacNee W, Magar Y, Magnan A, Mahboub B, Maier D, Majer I, Malva J, Manning P, Marshall GD, Masjedi MR, Mathieu-Dupas E, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Meltzer EO, Mercier J, Merk H, Miculinic N, Mihaltan F, Milenkovic B, Millot-Keurinck J, Mohammad Y, Momas I, Morais-Almeida M, Mösges R, Mullol J, Mullol J, Muraro A, Murray R, Naclerio R, Nadif R, Namazova-Baranova L, Neffen H, Nekam K, Nieto A, Niggemann B, Nogueira-Silva L, Nogues M, Nyembue TD, O'Hehir RE, Ohta K, Okamoto Y, Okubo K, Olive-Elias M, Ouedraogo S, Paggiaro P, Pali-Schöll I, Palkonen S, Panzner P, Papadopoulos NG, Papi A, Park HS, Passalacqua G, Pawankar R, Pedersen S, Pereira AM, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Pohl W, Popov TA, Portejoie F, Postma D, Potter P, Poulsen LK, Price D, Price D, Rabe KF, Raciborski F, Riechelmann H, Robalo-Cordeiro C, Roberts G, Rodenas F, Rodriguez-Mañas L, Rolland C, Roman Rodriguez M, Romano A, Rosado-Pinto J, Rosario N, Rottem M, Ryan D, Samolinski B, Sanchez-Borges M, Sastre-Dominguez J, Scadding GK, Schlosser R, Schmid-Grendelmeier P, Schunemann HJ, Scichilone N, Senior B, Serrano E, Sheikh A, Shields M, Simons F, Siroux V, Sisul JC, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stellato C, Stelmach R, Sterk PJ, Strandberg T, Sunyer J, Thijs C, Thomas M, Todo-Bom A, Tomazic PV, Toskala E, Triggiani M, Valenta R, Valero A, Valiulis A, Valovirta E, van Eerd M, van Ganse E, van Hague M, van Wick RG, Vandenplas O, Varona LL, Vazankari T, Vellas B, Ventura MT, Vezzani G, Viegi G, Voegels R, Vontetsianos T, Wagenmann M, Wahn U, Walker S, Wang DY, Wang Y, Werfel T, Whalley B, Wickman M, Williams DM, Williams S, Wilson N, Wormald PJ, Wright J, Yawn BP, Yiallouros PK, Yorgancioglu A, Young I, Yusuf OM, Zaidi A, Zar HJ, Zernotti ME, Zhang L, Zhong N, Zidarn M, Zuberbier T.
Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFPREA-ARIA-EPOS-AIRWAYS ICP statement.
Allergy 2017, doi: 10.1111/all.13162.
JRC IF (2016) = 7.361

Koren A, Rijavec M, Sodja E, Kern I, Sadikov A, Kovac V, Korosec P, Cufer T.
High BMI1 mRNA expression in peripheral whole blood is associated with favorable prognosis in advanced non-small-cell lung cancer patients.
Oncotarget 2017, 8 (15): 25384–25394. doi: 10.18632/oncotarget.15914.
JRC IF (2016) = 5.168

Marc Malovrh M, Rozman A, Škrgat S, Šilar M, Šelb J, Fležar M, Korošec P.
Bronchial thermoplasty induces immunomodulation with a significant increase in pulmonary CD4+24+ regulatory T cells.
Annals of Allergy, Asthma and Immunology 2017; pii: S1081-1206(17)30507-0. doi: 10.1016/j.anai.2017.06.019.
JRCIF (2016) = 3.728

Nina Turnšek Hitij, Izidor Kern, Aleksander Sadikov, Lea Knez, Karmen Stanič, Matjaž Zwitter, Tanja Cufer.
Immunohistochemistry for EGFR Mutation Detection in Non–Small-Cell Lung Cancer.
Clinical Lung Cancer 2017, 18 (3): e187–196.
JRC IF (2016) = 3.434

Andrea Rossi, Bojana Butorac-Petanjek, Marco Chilosi, Borja G Cosío, Matjaz Flezar, Nikolaos Koulouris, José Marin, Neven Miculinic, Guido Polese, Miroslav Samaržija, Sabina Skrgat, Theodoros Vassilakopoulos, Andrea Vukić-Dugac, Spyridon Zakynthinos, Marc Miravitlles.
Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research – a consensus document from six scientific societies International Journal of COPD 2017;12: 2593–2610.
JRC IF (2016): 3,157

Thunnissen E, Allen TC, Adam J, Aisner DL, Beasley MB, Borczuk AC, Cagle PT, Capelozzi VL, Cooper W, Hariri LP, Kern I, Lantuejoul S, Miller R, Mino-Kenudson M, Radonic T, Raparia K, Rekhtman N, Roy-Chowdhuri S, Russell P, Schneider F, Sholl LM, Tsao MS, Vivero M, Yatabe Y.
Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society.
Arch Pathol Lab Med. 2017 Jul 7. doi: 10.5858/arpa.2017-0106-SA.
JRC IF (2016): 2,918

Domen Ribnikar, Berta Sousa, Tanja Cufer, Fatima Cardoso.
Extended adjuvant endocrine therapy – A standard to all or some?
Breast 2017 (32): 112–118.
JRC IF (2016) = 2.801

Bousquet J, Bewick M, Cano A, Eklund P, Fico G, Goswami N, Guldemond NA, Henderson D, Hinkema MJ, Liotta G, Mair A, Molloy W, Monaco A, Monsonis-Paya I, Nizinska A, Papadopoulos H, Pavlickova A, Pecorelli S, Prados-Torres A, Roller-Wirnsberger RE, Somekh D, Vera-Muñoz C, Visser F, Farrell J, Malva J, Andersen Ranberg K, Camuzat T, Carriazo AM, Crooks G, Gutter Z, Iaccarino G, Manuel de Keenoy E, Moda G, Rodriguez-Mañas L, Vontetsianos T, Abreu C, Alonso J, Alonso-Bouzon C, Ankri J, Arredondo MT, Avolio F, Bedbrook A, Białoszewski AZ, Blain H, Bourret R, Cabrera-Umpierrez MF, Catala A, O'Caoimh R, Cesari M, Chavannes NH, Correia-da-Sousa J, Dedeu T, Ferrando M, Ferri M, Fokkens WJ, Garcia-Lizana F, Guérin O, Hellings PW, Haahtela T, Illario M, Inzerilli MC, Lodrup Carlsen KC, Kardas P, Keil T, Maggio M, Mendez-Zorrilla A, Menditto E, Mercier J, Michel JP, Murray R, Nogues M, O'Byrne-Maguire I, Pappa D, Parent AS, Pastorino M, Robalo-Cordeiro C, Samolinski B, Siciliano P, Teixeira AM, Tsartara SI, Valiulis A, Vandenplas O, Vasankari T, Vellas B, Vollenbroek-Hutten M, Wickman M, Yorgancioglu A, Zuberbier T, Barbagallo M, Canonica GW, Klimek L, Maggi S, Aberer W, Akdis C, Adcock IM, Agache I, Albera C, Alonso-Trujillo F, Angel Guarcia M, Annesi-Maesano I, Apostolo J, Arshad SH, Attalin V, Avignon A, Bachert C, Baroni I, Bel E, Benson M, Bescos C, Blasi F, Barbara C, Bergmann KC, Bernard PL, Bonini S, Bousquet PJ, Branchini B, Brightling CE, Bruguière V, Bunu C, Bush A, Caimmi DP, Calderon MA, Canovas G, Cardona V, Carlsen KH, Cesario A, Chkhartishvili E, Chiron R, Chivato T, Chung KF, d'Angelantonio M, De Carlo G, Cholley D, Chorin F, Combe B, Compas B, Costa DJ, Costa E, Coste O, Coupet AL, Crepaldi G, Custovic A, Dahl R, Dahlen SE, Demoly P, Devillier P, Didier A, Dinh-Xuan AT, Djukanovic R, Dokic D, Du Toit G, Dubakiene R, Dupeyron A, Emuzyte R, Fiocchi A, Wagner A, Fletcher M, Fonseca J, Fougère B, Gamkrelidze A, Garces G, Garcia-Aymeric J, Garcia-Zapirain B, Gemicioğlu B, Gouder C, Hellquist-Dahl B, Hermosilla-Gimeno I, Héve D, Holland C, Humbert M, Hyland M, Johnston SL, Just J, Jutel M, Kaidashev IP, Khaitov M, Kalayci O, Kalyoncu AF, Keijser W, Kerstjens H, Knezović J, Kowalski M, Koppelman GH, Kotska T, Kovac M, Kull I, Kuna P, Kvedariene V, Lepore V, MacNee W, Maggio M, Magnan A, Majer I, Manning P, Marcucci M, Marti T, Masoli M, Melen E, Miculinic N, Mihaltan F, Milenkovic B, Millot-Keurinck J, Mlinarić H, Momas I, Montefort S, Morais-Almeida M, Moreno-Casbas T, Mösges R, Mullol J, Nadif R, Nalin M, Navarro-Pardo E, Nekam K, Ninot G, Paccard D, Pais S, Palummeri E, Panzner P, Papadopoulos NK, Papanikolaou C, Passalacqua G, Pastor E, Perrot M, Plavec D, Popov TA, Postma DS, Price D, Raffort N, Reuzeau JC, Robine JM, Rodenas F, Robusto F, Roche N, Romano A, Romano V, Rosado-Pinto J, Roubille F, Ruiz F, Ryan D, Salcedo T, Schmid-Grendelmeier P, Schulz H, Schunemann HJ, Serrano E, Sheikh A, Shields M, Siafakas N, Scichilone N, Siciliano P, Skrindo I, Smit HA, Sourdet S, Sousa-Costa E, Spranger O, Sooronbaev T, Sruk V, Sterk PJ, Todo-Bom A, Touchon J, Tramontano D, Triggiani M, Tsartara SI, Valero AL, Valovirta E, van Ganse E, van Hage M, van den Berge M, Vandenplas O, Ventura MT, Vergara I, Vezzani G, Vidal D, Viegi G, Wagemann M, Whalley B, Wickman M, Wilson N, Yiallouros PK, Žagar M, Zaidi A, Zidarn M, Hoogerwerf EJ, Usero J, Zuffada R, Senn A, de Oliveira-Alves B.
Building Bridges for Innovation in Ageing: Synergies between Action Groups of the EIP on AHA.
Journal of Nutrition, Health & Aging 2017; 21 (1):92–104.
JRC IF (2016) = 2.772

Dutau H, Breen D, Bugalho A, Dalar L, Daniels J, Dooms C, Eberhardt R, Ek L, Encheva M, Febvre M, Hackl M, Marran S, Papai-Szekely Z, Perch M, Roglic M, Rosell A, Rozman A, Shah PL, Simon M, Szlubowski A, Stratakos G, Sundset A, Uibu T, Von Garnier C, Zaric B, Zdraveska M, Zuccatosta L, Bokan D, Arshad Husain S, Bilaceroglu S, Gasche-Soccal P, Gasparini S, Herth FJF, Munavvar M.
Current Practice of Airway Stenting in the Adult Population in Europe: A Survey of the European Association of Bronchology and Interventional Pulmonology (EABIP).
Respiration. 2017 Sep 8. doi: 10.1159/000480152.
JRC IF (2016): 2,772

D Kušar, U Zajc, V Jenčič, M Ocepek, J Higgins, M Žolnir-Dovč, M Pate
Mycobacteria in aquarium fish: results of a 3-year survey indicate caution required in handling pet-shop fish
J Fish Dis.2017 Jun;40(6):773-784.
JRC IF (2016): 2,138

Daniel Omersa, Tanja Čufer, Robert Marčun, Mitja Lainščak.
Echocardiography and cardiac biomarkers in patients with non-small cell lung cancer treated with platinum-based chemotherapy.
Radiology and Oncology 2017, 15 (1):15–22.
JRC IF (2016) = 1.681

Janzic U, Kern I, Janzic A, Cavka L, Cufer T.
PD-L1 Expression in Squamous-cell Carcinoma and Adenocarcinoma of the Lung
Radiol Oncol. 2017 Sep 14;51(3):357-362.
JRC IF (2016): 1,681

Mojca Humar, Izidor Kern, Gregor Vlacic, Vedran Hadzic, Tanja Cufer.
Insulin-like growth factor 1 receptor expression in advanced non-small-cell lung cancer and its impact on overall survival.
Radiology and Oncology 2017; 51 (2):195– 202.
JRC IF (2016) = 1.681

Planinšek Ručigaj T, Rijavec M, Miljkovič J, Šelb J, Korošec P.
A Novel Mutation in the FOXC2 Gene: A Heterozygous Insertion of Adenosine (c.867insA) in a Family with Lymphoedema of Lower Limbs without Distichiasis.
Radiol Oncol. 2017 Jul 6;51(3):363-368.
JRC IF (2016): 1,681

Dežman Katarina, Korošec P, Rupnik H, Rijavec M.
SPINK5 is associated with early-onset and CHI3L1 with late-onset atopic dermatitis.
International Journal of Immunogenetics 2017, doi: 10.1111/iji.12327.
JRCIF (2016) = 1.093

Kadivec S, Košnik M.
Benefits of venom immunotherapy: how soon can they be expected.
Srpski arhiv za celokupno lekarstvo 2017, doi:10.2298/SARH160307032K
JRC IF (2016) = 0.253

LJERKA KARADŽA-LAPIĆ, MATIJA RIJAVEC, KRISTINA KRALIK, ANA ĐANIĆ HADŽIBEGOVIĆ, SANJA DELIN, INGRID PRKAČIN, JOSIPA JOVIĆ ZLATOVIĆ, MITJA KOŠNIK, MARIJA ODAK and DRAŠKO CIKOJEVIĆ.
Improvement in the management od rare diseases in Croatia based on the protocol for hereditary angioedema
Acta Med Croatica, 71 (2017) 157-162
JRC IF (2014) = 0,218

Maja Malenica, Mira Šilar, Tanja Dujić, Tamer Bego, Sabina Semiz, Selma Škrbo, Besim Prnjavorac, Adlija Čaušević
Importance of inflammatory markers and IL-6 for diagnosis and follow up of patients with type 2 diabetes mellitus
Med Glas (Zenica) 2017; 14(2): 169-175.


2016

Hortobagyi GN, El-Saghir NS, Čufer T, Cazap E, de Guzman R, Othieno-Abinya NA, Sanchez JA, Pyle D.
The American Society of Clinical Oncology's Efforts to Support Global Cancer Medicine.
J Clin Oncol. 2016 Jan;34(1):76-82.
JRC IF (2014) = 18,428

Bousquet J, Schünemann HJ, Hellings PW, Arnavielhe S, Bachert C, Bedbrook A, Bergmann KC, Bosnic-Anticevich S, Brozek J, Calderon M, Canonica GW, Casale TB, Chavannes NH, Cox L, Chrystyn H, Cruz AA, Dahl R, De Carlo G, Demoly P, Devillier P, Dray G, Fletcher M, Fokkens WJ, Fonseca J, Gonzalez-Diaz SN, Grouse L, Keil T, Kuna P, Larenas-Linnemann D, Lodrup Carlsen KC, Meltzer EO, Mullol J, Muraro A, Naclerio RN, Palkonen S, Papadopoulos NG, Passalacqua G, Price D, Ryan D, Samolinski B, Scadding GK, Sheikh A, Spertini F, Valiulis A, Valovirta E, Walker S, Wickman M, Yorgancioglu A, Haahtela T, Zuberbier T; MASK study group*. Valovirta E42, Walker S43, Wickman M44, Yorgancioglu A45, Haahtela T46, Zuberbier T7; MASK study group* - Collaborators (224): Aberer W, Adachi M, Agache I, Akdis C, Akdis M, Annesi-Maesano I, Ansotegui IJ, Anto JM, Arshad SH, Baiardini I, Baigenzhin AK, Barbara C, Bateman ED, Beghé B, Bel EH, Ben Kheder A, Bennoor KS, Benson M, Bernstein D, Michael B, Thomas B, Bindslev-Jensen C, Bjermer L, Blain H, Boner A, Bonini M, Bonini S, Bosse I, Bouchard J, Boulet LP, Bourret RA, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Buhl R, Burney P, Bush A, Caballero-Fonseca F, Caimmi DP, Camargos P, Camuzat T, Carlsen KH, Carr W, Casale TB, Sarabia AC, Chatzi L, Chen Y, Chiron R, Chkhartishvili E, Chuchalin A, Ciprandi G, Cirule I, Correia de Sousa J, Costa D, Crooks G, Custovic A, Dahlen SE, Darsow U, De Blay F, De Manuel Keenoy E, Dedeu T, Deleanu D, Denburg J, Didier A, Dinh-Xuan AT, Dokic D, Douagui HB, Dubakiene R, Durham S, Dykewicz M, El-Gamal Y, Emuzyte R, Fink-Wagner A, Fiocchi A, Forastiere F, Gamkrelidze A, Gemicioğlu B, Gereda JE, Gerth van Wijk R, Gotua M, Grisle I, Guzmán MA, Haahtela T, Heinrich J, Hellquist-Dahl B, Horak F, Howarth PH, Humbert M, Hyland M, Ivancevich JC, Jares EJ, Johnston SL, Jonquet O, Joos G, Jung KS, Just J, Jutel M, Kaidashev IP, Khaitov M, Kalayci O, Kalyoncu F, Keith P, Khaltaev N, Kleine-Tebbe J, Klimek L, N'Goran BK, Kolek V, Koppelman GH, Kowalski M, Kull I, Kvedariene V, Lambrecht B, Lau S, Laune D, Le Thi Tuyet L, Li J, Lieberman P, Lipworth BJ, Renaud L, Magard Y, Magnan A, Mahboub B, Majer I, Makela M, Manning PJ, Masjedi MR, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Mercier J, Merk H, Miculinic N, Mihaltan F, Milenkovic B, Mohammad Y, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Mösges R, Nadif R, Namazova-Baranova L, Neffen H, Nekam K, Neou A, Niggemann B, Nyembue D, O'Hehir R, Ohta K, Okamoto Y, Okubo K, Ouedraogo S, Paggiaro PL, Pali-Schöll I, Palmer S, Panzner P, Papi A, Park HS, Pavord I, Pawankar R, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Pohl W, Popov T, Postma DS, Potter P, Poulsen LK, Rabe KF, Raciborski F, Pontal FR, Reitamo S, Repka-Ramirez MS, Robalo-Cordeiro C, Roberts G, Rodenas F, Rolland C, Rodriguez MR, Romano A, Rosado-Pinto J, Rosario NA, Rosenwasser L, Rottem M, Sanchez-Borges M, Sastre-Dominguez J, Schmid-Grendelmeier P, Serrano E, Simons FE, Sisul JC, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stelmach R, Strandberg T, Sunyer J, Thijs C, Todo-Bom AM, Triggiani M, Valenta R, Valero AL, van Hage M, Vandenplas O, Vezzani G, Vichyanond P, Viegi G, Wagenmann M, Wahn U, De Yun W, Williams D, Wright J, Yawn BP, Yiallouros P, Yusuf OM, Zar HJ, Zernotti M, Zhang L, Zhong N, Zidarn M.
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis.
J Allergy Clin Immunol. 2016 Aug;138(2):367-374.e2. doi: 10.1016/j.jaci.2016.03.025. Epub 2016 Apr 23.
JRC IF (2015) = 12,485

Novello S, Barlesi F, Califano R, Čufer T, Ekman S, Levra MG, Kerr K, Popat S, Reck M, Senan S, Simo GV, Vansteenkiste J, Peters S; ESMO Guidelines Committee. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ann Oncol. 2016 Sep;27(suppl 5):v1-v27.
JRC IF (2015) = 9,269

Bousquet J, Barbara C, Bateman E, Bel E, Bewick M, Chavannes NH, Cruz AA, Haahtela T, Hellings PW, Khaltaev N, Lodrup Carlsen K, Muraro A, Cordeiro CR, Rosado-Pinto J, Samolinski B, Strandberg T, Valiulis A, Yorgancioglu A, Zuberbier T; AIRWAYS-ICPs working group. Cordeiro CR13, Rosado-Pinto J14, Samolinski B15, Strandberg T16, Valiulis A17, Yorgancioglu A18, Zuberbier T19; AIRWAYS-ICPs working group - Collaborators (181): Adcock I, Addis A, Agache I, Agusti A, Alonso A, Annesi Maesano I, Anto JM, Baena-Cagnani C, Bai C, Baigenzhin A, Barnes PJ, Beck L, Bedbrook A, Benezet O, Bennoor KS, Benson M, Bindslev Jensen C, Blain H, Blasi F, Bonini M, Bonini S, Boulet LP, Bourdin A, Bourret R, Brightling CE, Briggs A, Brozek J, Buhl R, Bush A, Caimmi D, Calderon M, Calverley P, Camargos P, Canonica GW, Carlsen KH, Casale TB, Cazzola M, Cepeda Sarabia AM, Cesario A, Chen YZ, Chiron R, Chuchalin A, Chung KF, Cox L, Crooks G, Crooks MG, Custovic A, Dahl R, Dahlen SE, Dedeu T, Deleanu D, Demoly P, Devillier P, Didier A, Dinh Xuan AT, Djukanovic R, Dokic D, Douagui H, Eglin S, Elliot F, Emuzyte R, Fabbri L, Fink-Wagner A, Fletcher M, Fokkens WJ, Fonseca J, Franco A, Furber A, Gaga M, Gamkrelidze A, Garcia Aymerich J, González-Díaz S, Gouzi F, Garcés J, Guzmán MA, Hayot M, Heaney L, Heinrich J, Hooper J, Humbert M, Hyland M, Iaccarino G, Jakovenko D, Jardim J, Jenkins C, Johnston SL, Jonquet O, Joos G, Jung KS, Kalayci O, Karunanithi S, Keil T, Kolek V, Kowalski M, Kuna P, Kvedariene V, Le LT, Louis R, MacNee W, Mair A, Manning P, Manuel Keenoy ME, Majer I, Melén E, Melo Gomes E, Menzies-Gow A, Mercier G, Mercier J, Michel JP, Miculinic N, Mihaltan F, Milenkovic B, Momas I, Montilla-Santana A, Morais Almeida M, Morgan M, N'Diaye M, Nafti S, O'Hehir R, Ohta K, Paggiaro P, Palkonen S, Palmer S, Papadopoulos NG, Papi A, Passalacqua G, Pavord I, Pigearias B, Plavec D, Postma DS, Price D, Rabe KF, Radier Pontal F, Redon J, Rennard S, Roberts J, Roca J, Roche N, Rodenas F, Roggeri A, Rolland C, Ryan D, Sanchez-Borges M, Schünemann HJ, Sheikh A, Siafakas N, Sibille Y, Similowski T, Small I, Sola-Morales O, Sooronbaev T, Stelmach R, Sterk PJ, Stiris T, Sud P, To T, Todo Bom A, Triggiani M, Valenta R, Valero AL, Valovirta E, Vandenplas O, Van Ganse E, Vestbo J, Vezzani G, Viegi G, Visier L, Vogelmeier C, Vontetsianos T, Wagstaff R, Wallaert B, Wahn U, Whalley B, Williams D, Wilson N, Yawn BP, Yiallouros P, Yusuf O, Zar HJ, Zhong N, Zidarn M.
AIRWAYS-ICP2 (European Innovation Partnership on Active and Healthy Ageing) from concept to aimplementation.
Eur Respir J. 2016 Apr;47(4):1028-33. doi: 10.1183/13993003.01856-2015.
JRC IF (2015) = 8,332

Brockow K, Aberer W, Atanaskovic-Markovic M, Bavbek S, Bircher A, Bilo B, Blanca M, Bonadonna P, Burbach G, Calogiuri G, Caruso C, Celik G, Cernadas J, Chiriac A, Demoly P, Oude Elberink JN, Fernandez J, Gomes E, Garvey LH, Gooi J, Gotua M, Grosber M, Kauppi P, Kvedariene V, Laguna JJ, Makowska JS, Mosbech H, Nakonechna A, Papadopolous NG, Ring J, Romano A, Rockmann H, Sargur R, Sedlackova L, Sigurdardottir S, Schnyder B, Storaas T, Torres M, Zidarn M, Terreehorst I.
Drug allergy passport and other documentation for patients with drug hypersensitivity – An ENDA/EAACI Drug Allergy Interest Group Position Paper.
Allergy. 2016 Nov;71(11):1533-1539. doi: 10.1111/all.12929.
JRC IF (2015) = 6,335

Šelb J , Kogovšek R, Šilar M, Košnik M, Korošec P
Improved recombinant Api m1 and Ves v5 based IgE testing to dissect bee and yellow jacket allergy and their correlation with the severity of the sting reaction
Clin Exp Allergy. 2016 Apr;46(4):621-30.
JRC IF (2014) = 4,769

Vrdoljak E, Bodoky G, Jassem J, Popescu RA, Mardiak J, Pirker R, Čufer T, Bešlija S, Eniu A, Todorović V, Kubáčková K, Kurteva G, Tomašević Z, Sallaku A, Smichkoska S, Bajić Ž, Šikić BI.
Cancer Control in Central and Eastern Europe: Current Situation and Recommendations for Improvement.
Oncologist. 2016 Jul 8. pii: theoncologist.2016-0137.
JRC IF (2015) = 4,789

Karandža-Lapić L, Korošec P, Šilar M, Košnik M , Cikojević D, Lozić B, Rijavec M.
Frequent life-threatening laryngeal attacks in two Croatian families with hereditary angioedema due to C1 inhibitor deficiency harbouring a novel frameshift mutation in SERPING1.
Ann Med. 2016 May 17:1-7.
JRC IF (2014) = 3.886

P. M. Matricard, J. Kleine-Tebbe2, H. J. Hoffmann, R. Valenta,C. Hilger, S. Hofmaier, R. C. Aalberse, I. Agache, R. Asero, B. Ballmer-Weber, D. Barber, K. Beyer, T. Biedermann, M. B. Bilò, S. Blank, B. Bohle, P. P. Bosshard, H. Breiteneder, H. A. Brough, L. Caraballo, J. C. Caubet, R. Crameri, J. M. Davies, N. Douladiris, M. Ebisawa, P. A. EIgenmann, M. Fernandez-Rivas, F. Ferreira, G. Gadermaier, M. Glatz, R. G. Hamilton, T. Hawranek, P. Hellings, K. Hoffmann-Sommergruber, T. Jakob, U. Jappe, M. Jutel, S. D. Kamath, E. F. Knol, P. Korosec, A. Kuehn, G. Lack, A. L. Lopata, M. Mäkelä, M. Morisset, V. Niederberger, A. H. Nowak-Węgrzyn, N. G. Papadopoulos, E. A. Pastorello, G. Pauli, T. Platts-Mills, D. Posa, L. K. Poulsen, M. Raulf, J. Sastre, E. Scala, J. M. Schmid, P. Schmid-Grendelmeier, M. van Hage, R. van Ree, S. Vieths, R. Weber, M. Wickman, A. Muraro, M. Ollert
EAACI Molecular Allergology User’s Guide
Pediatric Allergy and Immunology 2016: 27: (suppl23): 1–250
JRC IF (2014) = 3,397

BLAZINA, Štefan, MARKELJ, Gašper, KOREN, Anja, TOPLAK, Nataša, BRATANIČ, Nevenka, JAZBEC, Janez, KOPAČ, Peter, DEBELJAK, Maruša, IHAN, Alojz, AVČIN, Tadej.
Autoimmune and inflammatory manifestations in 247 patients with primary immunodeficiency – a report from the Slovenian National Registry.
Journal of clinical immunology, ISSN 0271-9142, Nov. 2016, vol. 36, is. 8, str. 764-773
JRC IF (2015) = 3,094

Luzar J, Molek P, Šilar M, Korošec P, Košnik M, Štrukelj B, Lunder M.
Identification and characterization of major cat allergen Fel d 1 mimotopes on filamentous phage carriers.
Mol Immunol. 2016 Mar;71:176-83. doi: 10.1016/j.molimm.2016.02.004.
JRC IF (2015) = 2,275

Bousquet J, Hellings PW, Agache I, Bedbrook A, Bachert C, Bergmann KC, Bewick M, Bindslev-Jensen C, Bosnic-Anticevitch S, Bucca C, Caimmi DP, Camargos PA, Canonica GW, Casale T, Chavannes NH, Cruz AA, De Carlo G, Dahl R, Demoly P, Devillier P, Fonseca J, Fokkens WJ, Guldemond NA, Haahtela T, Illario M, Just J, Keil T, Klimek L, Kuna P, Larenas-Linnemann D, Morais-Almeida M, Mullol J, Murray R, Naclerio R, O'Hehir RE, Papadopoulos NG, Pawankar R, Potter P, Ryan D, Samolinski B, Schunemann HJ, Sheikh A, Simons FE, Stellato C, Todo-Bom A, Tomazic PV, Valiulis A, Valovirta E, Ventura MT, Wickman M, Young I, Yorgancioglu A, Zuberbier T, Aberer W, Akdis CA, Akdis M, Annesi-Maesano I, Ankri J, Ansotegui IJ, Anto JM, Arnavielhe S, Asarnoj A, Arshad H, Avolio F, Baiardini I, Barbara C, Barbagallo M, Bateman ED, Beghé B, Bel EH, Bennoor KS, Benson M, Białoszewski AZ, Bieber T, Bjermer L, Blain H, Blasi F, Boner AL, Bonini M, Bonini S, Bosse I, Bouchard J, Boulet LP, Bourret R, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Brozek J, Buhl R, Bunu C, Burte E, Bush A, Caballero-Fonseca F, Calderon MA, Camuzat T, Cardona V, Carreiro-Martins P, Carriazo AM, Carlsen KH, Carr W, Cepeda Sarabia AM, Cesari M, Chatzi L, Chiron R, Chivato T, Chkhartishvili E, Chuchalin AG, Chung KF, Ciprandi G, de Sousa JC, Cox L, Crooks G, Custovic A, Dahlen SE, Darsow U, Dedeu T, Deleanu D, Denburg JA, De Vries G, Didier A, Dinh-Xuan AT, Dokic D, Douagui H, Dray G, Dubakiene R, Durham SR, Du Toit G, Dykewicz MS, Eklund P, El-Gamal Y, Ellers E, Emuzyte R, Farrell J, Fink Wagner A, Fiocchi A, Fletcher M, Forastiere F, Gaga M, Gamkrelidze A, Gemicioğlu B, Gereda JE, van Wick RG, González Diaz S, Grisle I, Grouse L, Gutter Z, Guzmán MA, Hellquist-Dahl B, Heinrich J, Horak F, Hourihane JO, Humbert M, Hyland M, Iaccarino G, Jares EJ, Jeandel C, Johnston SL, Joos G, Jonquet O, Jung KS, Jutel M, Kaidashev I, Khaitov M, Kalayci O, Kalyoncu AF, Kardas P, Keith PK, Kerkhof M, Kerstjens HA, Khaltaev N, Kogevinas M, Kolek V, Koppelman GH, Kowalski ML, Kuitunen M, Kull I, Kvedariene V, Lambrecht B, Lau S, Laune D, Le LT, Lieberman P, Lipworth B, Li J, Lodrup Carlsen KC, Louis R, Lupinek C, MacNee W, Magar Y, Magnan A, Mahboub B, Maier D, Majer I, Malva J, Manning P, De Manuel Keenoy E, Marshall GD, Masjedi MR, Mathieu-Dupas E, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Meltzer EO, Mercier J, Merk H, Miculinic N, Mihaltan F, Milenkovic B, Millot-Keurinck J, Mohammad Y, Momas I, Mösges R, Muraro A, Namazova-Baranova L, Nadif R, Neffen H, Nekam K, Nieto A, Niggemann B, Nogueira-Silva L, Nogues M, Nyembue TD, Ohta K, Okamoto Y, Okubo K, Olive-Elias M, Ouedraogo S, Paggiaro P, Pali-Schöll I, Palkonen S, Panzner P, Papi A, Park HS, Passalacqua G, Pedersen S, Pereira AM, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Pohl W, Popov TA, Portejoie F, Postma D, Poulsen LK, Price D, Rabe KF, Raciborski F, Roberts G, Robalo-Cordeiro C, Rodenas F, Rodriguez-Mañas L, Rolland C, Roman Rodriguez M, Romano A, Rosado-Pinto J, Rosario N, Rottem M, Sanchez-Borges M, Sastre-Dominguez J, Scadding GK, Scichilone N, Schmid-Grendelmeier P, Serrano E, Shields M, Siroux V, Sisul JC, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stelmach R, Sterk PJ, Strandberg T, Sunyer J, Thijs C, Triggiani M, Valenta R, Valero A, van Eerd M, van Ganse E, van Hague M, Vandenplas O, Varona LL, Vellas B, Vezzani G, Vazankari T, Viegi G, Vontetsianos T, Wagenmann M, Walker S, Wang DY, Wahn U, Werfel T, Whalley B, Williams DM, Williams S, Wilson N, Wright J, Yawn BP, Yiallouros PK, Yusuf OM, Zaidi A, Zar HJ, Zernotti ME, Zhang L, Zhong N, Zidarn M.
AIRA 2016: Care pathways implementing emerging technologies for predictive medicine in rihinitis and asthma across the life cycle.
Clin Transl Allergy. 2016 Dec 30;6:47. doi: 10.1186/s13601-016-0137-4.
JRC IF (2016) = 3,239

Bousquet J, Farrell J, Crooks G, Hellings P, Bel EH, Bewick M, Chavannes NH, de Sousa JC, Cruz AA, Haahtela T, Joos G, Khaltaev N, Malva J, Muraro A, Nogues M, Palkonen S, Pedersen S, Robalo-Cordeiro C, Samolinski B, Strandberg T, Valiulis A, Yorgancioglu A, Zuberbier T, Bedbrook A, Aberer W, Adachi M, Agusti A, Akdis CA, Akdis M, Ankri J, Alonso A, Annesi-Maesano I, Ansotegui IJ, Anto JM, Arnavielhe S, Arshad H, Bai C, Baiardini I, Bachert C, Baigenzhin AK, Barbara C, Bateman ED, Beghé B, Kheder AB, Bennoor KS, Benson M, Bergmann KC, Bieber T, Bindslev-Jensen C, Bjermer L, Blain H, Blasi F, Boner AL, Bonini M, Bonini S, Bosnic-Anticevitch S, Boulet LP, Bourret R, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Brozek J, Buhl R, Burney PG, Bush A, Caballero-Fonseca F, Caimmi D, Calderon MA, Calverley PM, Camargos PA, Canonica GW, Camuzat T, Carlsen KH, Carr W, Carriazo A, Casale T, Cepeda Sarabia AM, Chatzi L, Chen YZ, Chiron R, Chkhartishvili E, Chuchalin AG, Chung KF, Ciprandi G, Cirule I, Cox L, Costa DJ, Custovic A, Dahl R, Dahlen SE, Darsow U, De Carlo G, De Blay F, Dedeu T, Deleanu D, De Manuel Keenoy E, Demoly P, Denburg JA, Devillier P, Didier A, Dinh-Xuan AT, Djukanovic R, Dokic D, Douagui H, Dray G, Dubakiene R, Durham SR, Dykewicz MS, El-Gamal Y, Emuzyte R, Fabbri LM, Fletcher M, Fiocchi A, Fink Wagner A, Fonseca J, Fokkens WJ, Forastiere F, Frith P, Gaga M, Gamkrelidze A, Garces J, Garcia-Aymerich J, Gemicioğlu B, Gereda JE, González Diaz S, Gotua M, Grisle I, Grouse L, Gutter Z, Guzmán MA, Heaney LG, Hellquist-Dahl B, Henderson D, Hendry A, Heinrich J, Heve D, Horak F, Hourihane JO, Howarth P, Humbert M, Hyland ME, Illario M, Ivancevich JC, Jardim JR, Jares EJ, Jeandel C, Jenkins C, Johnston SL, Jonquet O, Julge K, Jung KS, Just J, Kaidashev I, Kaitov MR, Kalayci O, Kalyoncu AF, Keil T, Keith PK, Klimek L, Koffi N'Goran B, Kolek V, Koppelman GH, Kowalski ML, Kull I, Kuna P, Kvedariene V, Lambrecht B, Lau S, Larenas-Linnemann D, Laune D, Le LT, Lieberman P, Lipworth B, Li J, Lodrup Carlsen K, Louis R, MacNee W, Magard Y, Magnan A, Mahboub B, Mair A, Majer I, Makela MJ, Manning P, Mara S, Marshall GD, Masjedi MR, Matignon P, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Meltzer EO, Menzies-Gow A, Merk H, Michel JP, Miculinic N, Mihaltan F, Milenkovic B, Mohammad GM, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Morgan M, Mösges R, Mullol J, Nafti S, Namazova-Baranova L, Naclerio R, Neou A, Neffen H, Nekam K, Niggemann B, Ninot G, Nyembue TD, O'Hehir RE, Ohta K, Okamoto Y, Okubo K, Ouedraogo S, Paggiaro P, Pali-Schöll I, Panzner P, Papadopoulos N, Papi A, Park HS, Passalacqua G, Pavord I, Pawankar R, Pengelly R, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Poethig D, Pohl W, Popov TA, Portejoie F, Potter P, Postma D, Price D, Rabe KF, Raciborski F, Radier Pontal F, Repka-Ramirez S, Reitamo S, Rennard S, Rodenas F, Roberts J, Roca J, Rodriguez Mañas L, Rolland C, Roman Rodriguez M, Romano A, Rosado-Pinto J, Rosario N, Rosenwasser L, Rottem M, Ryan D, Sanchez-Borges M, Scadding GK, Schunemann HJ, Serrano E, Schmid-Grendelmeier P, Schulz H, Sheikh A, Shields M, Siafakas N, Sibille Y, Similowski T, Simons FE, Sisul JC, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stelmach R, Sterk PJ, Sunyer J, Thijs C, To T, Todo-Bom A, Triggiani M, Valenta R, Valero AL, Valia E, Valovirta E, Van Ganse E, van Hage M, Vandenplas O, Vasankari T, Vellas B, Vestbo J, Vezzani G, Vichyanond P, Viegi G, Vogelmeier C, Vontetsianos T, Wagenmann M, Wallaert B, Walker S, Wang DY, Wahn U, Wickman M, Williams DM, Williams S, Wright J, Yawn BP, Yiallouros PK, Yusuf OM, Zaidi A, Zar HJ, Zernotti ME, Zhang L, Zhong N, Zidarn M, Mercier J.
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).
Clin Transl Allergy. 2016 Jul 29;6:29. doi: 10.1186/s13601-016-0116-9. Erratum in: Clin Transl Allergy. 2017 Feb 20;7:5.
JRC IF (2016) = 3,239

Judith A. C. Rietjens, Ida J. Korfage, Lesley Dunleavy, Nancy J. Preston, Lea J. Jabbarian, Caroline Arnfeldt Christensen, Maja de Brito, Francesco Bulli, Glenys Caswell, Branka Červ, Johannes van Delden, Luc Deliens, Giuseppe Gorini, Mogens Groenvold, Dirk Houttekier, Francesca Ingravallo, Marijke C. Kars, Urška Lunder, Guido Miccinesi, Alenka Mimić, Eugenio Paci, Sheila Payne, Suzanne Polinder, Kristian Pollock, Jane Seymour, Anja Simonič, Anna Thit Johnsen, Mariëtte N. Verkissen, Esther de Vries, Andrew Wilcock, Marieke Zwakman and Agnes van der Heide.
Advance care planning – a multi-centre cluster randomised clinical trial: the research protocol of the ACTION study.
BMC Cancer (2016) 16:264
JRC IF (2015) = 3,265

Zwitter M, Rajer M, Stanic K, Vrankar M, Doma A, Cuderman A, Grmek M, Kern I, Kovac V.
Intercalated chemotherapy and erlotinib for non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutations.
Cancer Biol Ther. 2016 Aug 2;17(8):833-9. doi: 10.1080/15384047.2016.1195049.
JRC IF (2015) = 2,921

Režonja R, Grabnar I, Mrhar A, Čebron Lipovec N, Čufer T, Vovk T.
A simple dried blood spot method for clinical pharmacological analyses of etoposide in cancer patients using liquid chromatography and fluorescence detection.
Clin Chim Acta. 2016 Jan 15;452:99-105
JRC IF (2014) = 2.824

Koren A, Rijavec M, Kern I, Sodja E, Korosec P, Cufer T.
BMI1, ALDH1A1, and CD133 Transcripts Connect Epithelial-Mesenchymal Transition to Cancer Stem Cells in Lung Carcinoma.
Stem Cells International. Volume 2016 (2016), Article ID 9714315, 9 pages.
JRC IF (2014) = 2,813

Boursier G, Vukasovic I, Meško Brguljan P, Lohmander M, Ghita I, Bernabeu Andreu FA, Barrett E, Brugnoni D, Kroupis C, Sprongl L, Thelen MH, Vanstapel F, Vodnik T, Huisman W, Vaubourdolle M; Working Group Accreditation and ISO/CEN standards (WG-A/ISO) of the EFLM.
Clin Chem Lab Med. 2016 Apr 1;54(4):545-51.
JRC IF (2014) = 2.707

Korošec P, Šilar M, Kopač P, Eržen R, Zidarn M, Košnik M.
Distinct Contributory Factors Determine Basophil-Allergen Sensitivity in Grass Pollen Rhinitis and in Anaphylactic Wasp Venom Allergy.
Int Arch Allergy Immunol. 2016 Dec 2;171(2):89-101.
JRC IF (2015) = 2,677

Čebron Lipovec N, Beijers RJ, van den Borst B, Doehner W, Lainscak M, Schols AM.
Sarcopenia in Advanced COPD Affects Cardiometabolic Risk Reduction by Short-Term High-intensity Pulmonary Rehabilitation
J Am Med Dir Assoc. 2016 Sep 1;17(9):814-20.
JRC IF (2014) = 2,673

Marčun R, Stanković I, Vidaković R, Farkaš J, Kadivec S, Putniković B, Ilić I, Nešković AN, Lainščak M
Prognostic implications of heart failure with preserved ejection fraction in patients with an exacerbation of chronic obstructive pulmonary disease
Intern Emerg Med. 2016 Jun;11(4):519-27.
JRC IF (2014) = 2,624

Rozman A, Camlek L, Marc Malovrh M, Kern I, Schönfeld N.
Feasibility and safety of pariental pleural cryobiopsy during semi-rigid thoracosocopy.
Clin Respir J. 2016 Sep;10(5):574-8. doi: 10.1111/crj.12256.
JRC IF (2015) = 2,147

Čebron Lipovec N, Beijers RJ, van den Borst B, Doehner W, Lainscak M, Schols AM.
The Prevalence of Metabolic Syndrome In Chronic Obstructive Pulmonary Disease: A Systematic Review.
COPD. 2016 Jun;13(3):399-406. doi: 10.3109/15412555.2016.1140732. Epub 2016 Feb 25.
JRC IF (2014) = 2,16

Žavbi M, Korošec P, Fležar M, Škrgat M, Marc Malovrh M, Rijavec M
Polymorphisms and haplotypes of the chromosome locus 17q12-17q21.1 contribute to adult asthma susceptibility in Slovenian patients
Hum Immunol. 2016 Jun;77(6):527-34.
JRC IF (2014) = 2,138

Daniel Omersa, Tanja Čufer, Robert Marčun, Mitja Lainščak
Echocardiography and cardiac biomarkers in patients with non-small cell lung cancer treated with platinum-based chemotherapy
Radiol Oncol 2016; epub ahead of print. DOI: 10.1515/raon-2016-0037
JRC IF (2014) = 1,912

Sodja E, Rijavec M, Koren A, Sadikov A, Korošec P, Čufer T
The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer
Radiol Oncol 2016; 50 (2): 188-96.
JRC IF (2014) = 1,912

Zimet Zlatko, Bilban Marjan, Marc Malovrh Mateja, Korošec Peter, Poljšak Borut, Osredkar Joško, Šilar Mira.
8-isoprostane as oxidative stress maker in coal mine workers.
Biomed Environ Sci. 2016 Aug;29(8):589-593.
JRC IF (2015) = 1,906

Brcic L, Jakopovic M, Misic M, Seiwerth F, Kern I, Smojver-Jezek S, Quehenberger F, Samarzija M, Seiwerth S.
Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia.
Diagn Pathol. 2016 Sep 21;11(1):90.
JRC IF (2015) = 1,895

BEVC, Sebastjan, PURG, Darinka, KNEHTL, Maša, HREN, Martin, TURNŠEK HITIJ, Nina, HOJS, Nina, ZORMAN, Tadej, DVORŠAK, Benjamin, EKART, Robert, HOJS, Radovan.
Ankle-brachial index and long-term (10 years) survival of nondiabetic hemodialysis patients.
Therapeutic apheresis and dialysis, ISSN 1744-9987, 2016, vol. 20, issue 3, str. 277-280. doi: 10.1111/1744-9987.12437
JRC IF (2015) = 1,477

Mercedes Lovrecic, Julij Selb, Kristina Selb, and Barbara Lovrecic
Illicit drug-related suicide mortality and identification of initially unrecognized
Heroin Addict Relat Clin Probl 2016;18(4):51-54.
JRC IF (2014) = 0,643

LOVREČIČ, Mercedes, ŠELB, Julij Gyula, ŠELB, Kristina, LOVREČIČ, Barbara.
Suicide among heroin addicts in Opioid Agonist Treatment in Slovenia: the impact of age at cogort treatment entry and of gender on suicide.
Heroin addiction and related clinical problems, 2016, vol. 18, no. 5, str. 49-50.
JRC IF (2015) = 0,579


2015

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Coleman R, Powles T, Paterson A, Gnant M, Anderson S, Diel I, Gralow J, von Minckwitz G, Moebus V, Bergh J, Pritchard KI, Bliss J, Cameron D, Evans V, Pan H, Peto R, Bradley R, Gray R.(7628collaborators inc. T. Cufer)
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.
Lancet. 2015 Oct 3;386(10001):1353-61.
JRC IF (2014) = 45,217

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Dowsett M, Forbes JF, Bradley R, Ingle J, Aihara T, Bliss J, Boccardo F, Coates A, Coombes RC, Cuzick J, Dubsky P, Gnant M, Kaufmann M, Kilburn L, Perrone F, Rea D, Thürlimann B, van de Velde C, Pan H, Peto R, Davies C, Gray R. (764 collaborators inc. T. Cufer)
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.
Lancet. 2015 Oct 3;386(10001):1341-52.
JRC IF (2014) = 45,215

Hortobagyi GN, El-Saghir NS, Čufer T, Cazap E, de Guzman R, Othieno-Abinya NA, Sanchez JA, Pyle D.
The American Society of Clinical Oncology's Efforts to Support Global Cancer Medicine.
J Clin Oncol. 2016 Jan;34(1):76-82.
JRC IF (2014) = 18,428

Buhl R, Maltais F, Abrahams R, Bjermer L, Derom E, Ferguson G, Fležar M, Hébert J, McGarvey L, Pizzichini E, Reid J, Veale A, Grönke L, Hamilton A, Korducki L, Tetzlaff K, Waitere-Wijker S, Watz H, Bateman E.
Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4).
Eur Respir J. 2015 Apr;45(4):969-79.
JRC IF (2014) = 7,636

Müllerova H, Maselli DJ, Locantore N, Vestbo J, Hurst JR, Wedzicha JA, Bakke P, Agusti A, Anzueto A; ECLIPSE Investigators. 61 collaborators inc. Kosnik M.
Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort.
Chest. 2015 Apr;147(4):999-1007.
JRC IF (2014) = 7,483

Laszlo V, Hoda MA, Garay T, Pirker C, Ghanim B, Klikovits T, Dong YW, Rozsas A, Kenessey I, Szirtes I, Grusch M, Jakopovic M,Samarzija M, Brcic L, Kern I, Rozman A, Popper H, Zöchbauer-Müller S, Heller G, Altenberger C, Ziegler B, Klepetko W, Berger W, Dome B, Hegedus B.
Epigenetic downregulation of integrin α7 increases migratory potential and confers poor prognosis in malignant pleural mesothelioma.
J Pathol. 2015 May 26.
JRC IF (2014) = 7,429

Gourgou-Bourgade S, Cameron D, Poortmans P, Asselain B, Azria D, Cardoso F, A'Hern R, Bliss J, Bogaerts J, Bonnefoi H, Brain E,Cardoso MJ, Chibaudel B, Coleman R, Cufer T, Dal Lago L, Dalenc F, De Azambuja E, Debled , Delaloge S, Filleron T, Gligorov J, Gutowski M,Jacot W,Kirkove C, MacGrogan G, Michiels S, Negreiros I, Offersen BV, Penault Llorca F, Pruneri G, Roche H, Russell NS, Schmitt F, Servent V, Thürlimann B, Untch M, van der Hage JA, van Tienhoven G, Wildiers H, Yarnold J, Bonnetain F, Mathoulin-Pélissier S,Bellera C, Dabakuyo-Yonli TS.
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). (suplementi)
Ann Oncol. 2015 May;26(5):873-879.
JRC IF (2014) = 7,04

Motaln H, Koren A, Gruden K, Ramšak Ž, Schichor C, Lah TT
Heterogeneous glioblastoma cell cross-talk promotes phenotype alterations and enhanced drug resistance + suppl
Oncotarget. 2015 Dec 1;6(38):40998-1017.
JRC IF (2014) = 6,359

Bousquet J, Schunemann HJ, Fonseca J, Samolinski B, Bachert C, Canonica GW, Casale T, Cruz AA, Demoly P, Hellings P, Valiulis A, Wickman M, Zuberbier T, Bosnic-Anticevitch S, Bedbrook A, Bergmann KC, Caimmi D, Dahl R, Fokkens WJ, Grisle I, Lodrup Carlsen K, Mullol J, Muraro A, Palkonen S, Papadopoulos N, Passalacqua G, Ryan D, Valovirta E, Yorgancioglu A, Aberer W, Agache I, Adachi M, Akdis CA, Akdis M, Annesi-Maesano I, Ansotegui IJ, Anto JM, Arnavielle S, Arshad H, Baiardini I, Baigenzhin AK, Barbara C, Bateman ED, Beghé B, Bel EH, Ben Kheder A, Bennoor KS, Benson M, Bewick M, Bieber T, Bindslev-Jensen C, Bjermer L, Blain H, Boner AL, Boulet LP, Bonini M, Bonini S, Bosse I, Bourret R, Bousquet PJ, Braido F, Briggs AH, Brightling CE, Brozek J, Buhl R, Burney PG, Bush A, Caballero-Fonseca F, Calderon MA, Camargos P, Camuzat T, Carlsen KH, Carr W, Cepeda Sarabia AM, Chavannes NH, Chatzi L, Chen YZ, Chiron R, Chkhartishvili E, Chuchalin AG, Ciprandi G, Cirule I, Correia de Sousa J, Cox L, Crooks G, Costa DJ, Custovic A, Dahlen SE, Darsow U, De Carlo G, De Blay F, Dedeu T, Deleanu D, Denburg JA, Devillier P, Didier A, Dinh-Xuan AT, Dokic D, Douagui H, Dray G, Dubakiene R, Durham SR, Dykewicz MS, El-Gamal Y, Emuzyte R, Fink Wagner A, Fletcher M, Fiocchi A, Forastiere F, Gamkrelidze A, Gemicioğlu B, Gereda JE, González Diaz S, Gotua M, Grouse L, Guzmán MA, Haahtela T, Hellquist-Dahl B, Heinrich J, Horak F, Hourihane J, Howarth P, Humbert M, Hyland ME, Ivancevich JC, Jares EJ, Johnston SL, Joos G, Jonquet O, Jung KS, Just J, Kaidashev I, Kalayci O, Kalyoncu AF, Keil T, Keith PK, Khaltaev N, Klimek L, N'Goran BK, Kolek V, Koppelman GH, Kowalski ML, Kull I, Kuna P, Kvedariene V, Lambrecht B, Lau S, Larenas-Linnemann D, Laune D, Le L, Lieberman P, Lipworth B, Li J, Louis R, Magard Y, Magnan A, Mahboub B, Majer I, Makela MJ, Manning P, De Manuel Keenoy E, Marshall GD, Masjedi, Maurer M, Mavale-Manuel S, Melén E, Melo-Gomes E, Meltzer EO, Merk H, Miculinic N, Mihaltan F, Milenkovic B, Mohammad Y, Molimard M, Momas I, Montilla-Santana A, Morais-Almeida M, Mösges R, Namazova-Baranova L, Naclerio R, Neou A, Neffen H, Nekam K, Niggemann B, Nyembue TD, O'Hehir RE, Ohta K, Okamoto Y, Okubo K, Ouedraogo S, Paggiaro P, Pali-Schöll I, Palmer S, Panzner P, Papi A, Park HS, Pavord I, Pawankar R, Pfaar O, Picard R, Pigearias B, Pin I, Plavec D, Pohl W, Popov TA, Portejoie F, Postma D, Potter P, Price D, Rabe KF, Raciborski F, Radier Pontal F, Repka-Ramirez S, Robalo-Cordeiro C, Rolland C, Rosado-Pinto J, Reitamo S, Rodenas F, Roman Rodriguez M, Romano A, Rosario N, Rosenwasser L, Rottem M, Sanchez-Borges M, Scadding GK, Serrano E, Schmid-Grendelmeier P, Sheikh A, Simons F, Sisul JC, Skrindo I, Smit HA, Solé D, Sooronbaev T, Spranger O, Stelmach R, Strandberg T, Sunyer J, Thijs C, Todo-Bom A, Triggiani M, Valenta R, Valero AL, van Hage M, Vandenplas O, Vezzani G, Vichyanond P, Viegi G, Wagenmann M, Walker S, Wang DY, Wahn U, Williams DM, Wright J, Yawn BP, Yiallouros PK, Yusuf OM, Zar HJ, Zernotti ME, Zhang L, Zhong N, ZIDARN M, Mercier J.
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation. Allergy. 2015 Nov;70(11):1372-92.
JRC IF (2014) = 6,312

Hoffmann HJ, Santos AF, Mayorga C, Nopp A, Eberlein B, Ferrer M, Rouzaire P, Ebo DG, Sabato V, Sanz ML, Pecaric-Petkovic T, Patil SU, Hausmann OV, Shreffler WG, Korosec P, Knol EF.
The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease.
Allergy. 2015 Jul 21.
JRC IF (2014) = 6,028

Bousquet J, Zidarn M et al.
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation.
Allergy. 2015 Jul 4.
JRC IF (2014) = 6,028

Zidarn M, Košnik M, Šilar M, Bajrović N, Korošec P.
Sustained effect of grass pollen subcutaneous immunotherapy on suppression of allergen-specific basophil response; a real-life, nonrandomized controlled study.
Allergy. 2015 May;70(5):547-55.
JRC IF (2014) = 6,028

O'Brien ME, Gaafar R, Hasan B, Menis J, Cufer T, Popat S, Woll PJ, Surmont V, Georgoulias V, Montes A, Blackhall F,Hennig I, Schmid-Bindert G, Baas P; EORTC-LCG.
Maintenance pazopanib versus placebo in Non-Small Cell Lung Cancer patients non-progressive after first line chemotherapy: A double blind randomised phase III study of the lung cancer group, EORTC 08092 (EudraCT: 2010-018566-23, NCT01208064).
Eur J Cancer. 2015 Jun 11.
JRC IF (2014) = 5,417

Tryfonidis K, Basaran G, Bogaerts J, Debled M, Dirix L, Thery JC, Tjan-Heijnen VC, Van den Weyngaert D, Cufer T, Piccart M, Cameron D11; EORTC-Breast Cancer Group.
A European Organisation for Research and Treatment of Cancer randomized, double-blind, placebo-controlled, multicentre phase II trial of anastrozole in combination with gefitinib or placebo in hormone receptor-positive advanced breast cancer (NCT00066378).
Eur J Cancer. 2015 Dec 24;53:144-154.
JRC IF (2014) = 5,417

Hetem DJ, Derde LP, Empel J, Mroczkowska A, Orczykowska-Kotyna M, Kozińska A, Hryniewicz W, Goossens H, Bonten MJ; MOSAR WP3 Study Group (78 collaborators incl. Tomič V, Novak M, Vrankar K)
IMolecular epidemiology of MRSA in 13 ICUs from eight European countries + suppll
J Antimicrob Chemother. 2016 Jan;71(1):45-52.
JRC IF (2014) = 5,315

Papagiannitsis CC, Izdebski R, Baraniak A, Fiett J, Herda M, Hrabák J, Derde LP, Bonten MJ, Carmeli Y, Goossens H, Hryniewicz W, Brun-Buisson C, Gniadkowski M; MOSAR WP2, WP3 and WP5 study groups; Collaborators: Grabowska A, Nikonorow E, Dautzenberg MJ, Adler A, Kazma M, Navon-Venezia S, Malhotra-Kumar S, Lammens C, Legrand P, Annane D, Chalfine A, Giamarellou H, Petrikkos GL, Nardi G, Balode A, Dumpis U, Stammet P, Arag I, Esteves F, Muzlovic I, Tomic V, Mart AT, Lawrence C, Salomon J, Paul M, Lerman Y, Rossini A, Salvia A, Samso JV, Fierro J.
Survey of metallo-β-lactamase-producing Enterobacteriaceae colonizing patients in European ICUs and rehabilitation units, 2008-11. J Antimicrob Chemother. 2015 Jul;70(7):1981-8.
JRC IF (2014) = 5,313

Ramlau R, Cufer T, Berzinec P, Dziadziuszko R, Olszewski W, Popper H, Bajcic P, Dušek L, Zbozinkova Z, Pirker R; INSIGHT study team.
Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer in the Real-World Setting in Central Europe: The INSIGHT Study.
J Thorac Oncol. 2015 Sep;10(9):1370-4.
JRC IF (2014) = 5,282

Ghanim B, Klikovits T, Hoda MA, Lang G, Szirtes I, Setinek U, Rozsas A, Renyi-Vamos F, Laszlo V, Grusch M, Filipits M, Scheed A, Jakopovic M, Samarzija M, Brcic L, Stancic-Rokotov D, Kern I, Rozman A, Dekan G, Klepetko W, Berger W, Glasz T, Dome B, Hegedus B.
Ki67 index is an independent prognostic factor in epithelioid but not in non-epithelioid malignant pleural mesothelioma: a multicenter study.
Br J Cancer. 2015 Mar 3;112(5):783-92.
JRC IF (2014) = 4,836

Korošec P, Žiberna K, Šilar M, Dežman M, Čelesnik Smodiš N, Rijavec M, Kopač P, Eržen R, Lalek N, Bajrović N, Košnik M, Zidarn M.
Immunological and clinical factors associated with adverse systemic reactions during the build-up phase of honeybee venom immunotherapy.
Clin Exp Allergy. 2015 Oct;45(10):1579-89.
JRC IF (2014) = 4,769

Šelb J, Kogovšek R, Šilar M, Košnik M, Korošec P.
Improved recombinant Api m1 and Ves v5 based IgE testing to dissect bee and yellow jacket allergy and their correlation with the severity of the sting reaction.
Clin Exp Allergy. 2015 Sep 14.
JRC IF (2014) = 4,769

Rupnik H, Rijavec M, Korošec P.
Filaggrin loss-of-function mutations are not associated with atopic dermatitis that develops in late childhood or adulthood.
Br J Dermatol. 2015 Feb;172(2):455-61.
JRC IF (2014) = 4,275

Lee JH, Cho MH, Hersh CP, McDonald ML, Wells JM, Dransfield MT, Bowler RP, Lynch DA, Lomas DA, Crapo JD, Silverman EK; COPDGene and ECLIPSE Investigators. 273 collaborators inc. Kosnik M.
IREB2 and GALC are associated with pulmonary artery enlargement in chronic obstructive pulmonary disease.
Am J Respir Cell Mol Biol. 2015 Mar;52(3):365-76.
JRC IF (2014) = 3.985

Andrejević S, Korošec P, Šilar M, Košnik M, Mijanović R, Bonači-Nikolić B, Rijavec M
Hereditary Angioedema Due to C1 Inhibitor Deficiency in Serbia: Two Novel Mutations and Evidence of Genotype-Phenotype Association
PLoS One. 2015 Nov 4;10(11):e0142174.
JRC IF (2014) = 3,234

Beeh KM, LaForce C, Gahlemann M, Wenz A, Toorawa R, Fležar M.
Randomised, double-blind, placebo-controlled crossover study to investigate different dosing regimens of olodaterol delivered via Respimat® in patients with moderate to severe persistent asthma.
Respir Res. 2015 Jul 16;16:87.
JRC IF (2014) = 3,093

Koren A, Sodja E, Rijavec M, Jez M, Kovac V, Korosec P, Cufer T.
Prognostic value of cytokeratin-7 mRNA expression in peripheral whole blood of advanced lung adenocarcinoma patients.
Cell Oncol (Dordr). 2015 Aug 26.
JRC IF (2014) = 3,032

Koren A, Rijavec M, Kern I, Sodja E, Korosec P, Cufer T.
BMI1, ALDH1A1, and CD133 Transcripts Connect Epithelial-Mesenchymal Transition to Cancer Stem Cells in Lung Carcinoma
Stem Cells International, Article ID 652310, in press
JRC IF (2014) = 2,813

Thelen MH, Vanstapel FJ, Kroupis C, Vukasovic I, Boursier G, Barrett E, Andreu FB, Brguljan PM, Brugnoni D, Lohmander M, Sprongl L, Vodnik T, Ghita I, Vaubourdolle M, Huisman W; Working Group Accreditation ISO/CEN standards (WG-A/ISO) of EFLM.
Flexible scope for ISO 15189 accreditation: a guidance prepared by the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group Accreditation and ISO/CEN standards (WG-A/ISO).
Clin Chem Lab Med. 2015 Jul;53(8):1173-80.
JRC IF (2014) = 2,707

Kosnik M, Korosec P.
Venom immunotherapy: clinical efficacy, safety and contraindications.
Expert Rev Clin Immunol. 2015 May 27:1-8.
JRC IF (2014) = 2,484

Ferguson GT, Fležar M, Korn S, Korducki L, Grönke L, Abrahams R, Buhl R.
Efficacy of Tiotropium + Olodaterol in Patients with Chronic Obstructive Pulmonary Disease by Initial Disease Severity and Treatment Intensity: A Post Hoc Analysis.
Adv Ther. 2015 Jun;32(6):523-36.
JRC IF (2014) = 2,272

Rezonja KR, Grabnar I, Vovk T, Mrhar A, Kovac V, Cufer T.
Febrile neutropenia in chemotherapy treated small-cell lung cancer patients .
Radiol Oncol. 2015 June 49(2):173-180.
JRC IF (2014) = 1,912

Rozman A, Marc MM, Adamic K, Subic T, Kovac V, Flezar M.
Endobronchial ultrasound elastography strain ratio for mediastinal lymph node diagnosis.
Radiol Oncol. 2015 June.
JRC IF (2014) = 1,912

Sodja E, Rijavec M, Koren A, Sadikov A, Korošec P, Cufer T.
The prognostic value of whole blood SOX2, NANOG and OCT4 mRNA expression in advanced small-cell lung cancer.
Radiol Oncol. 2015 June.
JRC IF (2014) = 1,912

Luznik D, Kosnik M, Tomic V.
Comparison of Seeplex PneumoBacter aCE detection assay and in-house multiplex PCR for the identification of Streptococcus pneumoniae.
New Microbiol. 2015 Jan;38(1):51-8.
JRC IF (2014) = 1,784

Rozman A, Camlek L, Marc Malovrh M, Kern I, Schönfeld N.
Feasibility and safety of parietal pleural cryobiopsy during semi-rigid thoracoscopy.
Clin Respir J. 2014 Dec 16.
JRC IF (2014) = 1,512


2014

Derde LP, Cooper BS, Goossens H, Malhotra-Kumar S, Willems RJ, Gniadkowski M, Hryniewicz W, Empel J, Dautzenberg MJ, Annane D7, Aragão I, Chalfine A, Dumpis U, Esteves F, Giamarellou H, Muzlovic I, Nardi G, Petrikkos GL, Tomic V, Martí AT, Stammet P, Brun-Buisson C, Bonten MJ; MOSAR WP3 Study Team.
Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial.
Lancet Infect Dis. 2014 Jan;14(1):31-9.
JRC IF = 22,433

Vestbo J, Agusti A, Wouters EF, Bakke P, Calverley PM, Celli B, Coxson H, Crim C, Edwards LD, Locantore N, Lomas DA, MacNee W, Miller B, Rennard SI, Silverman EK, Yates JC, Tal-Singer R; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints Study Investigators. 69 collaborators incl. Kosnik M.
Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team.
Am J Respir Crit Care Med. 2014 May 1;189(9):1022-30.
JRC IF = 12,996

McDonald ML1, Cho MH, Sørheim IC, Lutz SM, Castaldi PJ, Lomas DA, Coxson HO, Edwards LD, MacNee W, Vestbo J, Yates JC, Agusti A, Calverley PM, Celli B, Crim C, Rennard SI, Wouters EF, Bakke P, Tal-Singer R, Miller BE, Gulsvik A, Casaburi R, Wells JM, Regan EA, Make BJ, Hokanson JE, Lange C, Crapo JD, Beaty TH, Silverman EK, Hersh CP; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints and COPDGene Investigators. 257 collaborators incl. Kosnik M.
Common genetic variants associated with resting oxygenation in chronic obstructive pulmonary disease.
Am J Respir Cell Mol Biol. 2014 Nov;51(5):678-87.
JRC IF = 11,279

Cho MH, McDonald ML, Zhou X, Mattheisen M, Castaldi PJ, Hersh CP, Demeo DL, Sylvia JS, Ziniti J, Laird NM, Lange C, Litonjua AA, Sparrow D, Casaburi R, Barr RG, Regan EA, Make BJ, Hokanson JE, Lutz S, Dudenkov TM, Farzadegan H, Hetmanski JB, Tal-Singer R, Lomas DA, Bakke P, Gulsvik A, Crapo JD, Silverman EK, Beaty TH; NETT Genetics, ICGN, ECLIPSE and COPD Gene Investigators. 276 colleborators incl. Kosnik M
Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis.
Lancet Respir Med. 2014 Mar;2(3):214-25.
JRC IF = 9,629

Bonnefoi H, Litière S, Piccart M, MacGrogan G, Fumoleau P, Brain E, Petit T, Rouanet P, Jassem J, Moldovan C, Bodmer A, Zaman K, Cufer T, Campone M, Luporsi E, Malmström P, Werutsky G, Bogaerts J, Bergh J, Cameron DA;EORTC
Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial. 10994/BIG 1-00 Study investigators.
Ann Oncol. 2014 Jun;25(6):1128-36.
JRC IF = 7,040

Cardoso F, Costa A, Norton L, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Biganzoli L, Blackwell KL, Cardoso MJ, Cufer T, El Saghir N, Fallowfield L, Fenech D, Francis P, Gelmon K, Giordano SH, Gligorov J, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Krop I, Kyriakides S, Lin UN, Mayer M, Merjaver SD, Nordström EB, Pagani O, Partridge A, Penault-Llorca F, Piccart MJ, Rugo H, Sledge G, Thomssen C, Van't Veer L, Vorobiof D, Vrieling C, West N, Xu B, Winer E.
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).
Ann Oncol. 2014 Oct;25(10):1871-88.
JRC IF = 7,040

Düngen HD, Musial-Bright L, Inkrot S, Apostolović S, Edelmann F, Lainščak M, Sekularac N, Störk S, Tahirovic E, Tscholl V, Krackhardt F, Loncar G, Trippel TD, Gelbrich G.
Heart rate following short-term beta-blocker titration predicts all-cause mortality in elderly chronic heart failure patients: insights from the CIBIS-ELD trial.
Eur J Heart Fail. 2014 Aug;16(8):907-14.
JRC IF = 6,526

McDonagh TA, Gardner RS, Lainscak M, Nielsen OW, Parissis J, Filippatos G, Anker SD.
Heart failure association of the European society of cardiology specialist heart failure curriculum.
Eur J Heart Fail. 2014 Feb;16(2):151-62.
JRC IF = 6,526

Rijavec M, Korošec P, Žavbi M, Kern I, Malovrh MM.
Let-7a is differentially expressed in bronchial biopsies of patients with severe asthma.
Sci Rep. 2014 Aug 18;4:6103
JRC IF = 5,578

EBCTCG (Early Breast Cancer Trialists' Collaborative Group), McGale P, Taylor C, Correa C, Cutter D, Duane F, Ewertz M, Gray R, Mannu G, Peto R, Whelan T, Wang Y, Wang Z, Darby S. 635 collaborators incl. Cufer T.
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.
Lancet. 2014 Jun 21;383(9935):2127-35.
JRC IF = 5,217

Gustot T, Felleiter P, Pickkers P, Sakr Y, Rello J, Velissaris D, Pierrakos C, Taccone FS, Sevcik P, Moreno C, Vincent JL; EPIC II Group of Investigators. 1229 collaborators incl. Tomic V.
Impact of infection on the prognosis of critically ill cirrhotic patients: results from a large worldwide study.
Liver Int. 2014 Nov;34(10):1496-503.
JRC IF = 4,850

Parissis JT, Andreoli C, Kadoglou N, Ikonomidis I, Farmakis D, Dimopoulou I, Iliodromitis E, Anastasiou-Nana M, Lainscak M, Ambrosio G, Mebazaa A, Filippatos G, Follath F.
Differences in clinical characteristics, management and short-term outcome between acute heart failure patients chronic obstructive pulmonary disease and those without this co-morbidity.
Clin Res Cardiol. 2014 Sep;103(9):733-41.
JRC IF = 4,560

Neskovic AN, Lainscak M.
Functional capacity in heart failure with preserved ejection fraction: looking for interactions and explanations.
Int J Cardiol. 2014 Mar 15;172(2):295-6.
JRC IF = 4,036

Tavazzi L, Swedberg K, Komajda M, Böhm M, Borer JS, Lainscak M, Robertson M, Ford I; SHIFT Investigators.
Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study.
Int J Cardiol. 2013 Dec 10;170(2):182-8.
JRC IF = 4,036

Bidovec-Stojkovič U, Seme K,Žolnir-Dovč M, Supply P.
Prospective Genotyping of Mycobacterium tuberculosis from Fresh Clinical Samples.
PLoS One. 2014 Oct 14;9(10):e109547.
JRC IF = 3,234

Čelesnik N, Šilar M, Eržen R, Rijavec M, Korošec P.
Down-Regulation of FceRI-Mediated CD63 Basophil Response during Short-Term VIT Determined Venom-Nonspecific Desensitization.
PLOS ONE April 2014, 9(4): e94762.
JRC IF = 3,234

Osolnik K, Rijavec M, Korosec P.
Disposal of iNKT cell deficiency and an increase in expression of SLAM signalling factors characterizes sarcoidosis remission: a 4-year longitudinal study.
Respir Res. 2014 Aug 21;15:91.
JRC IF = 3,093

Lee JH, McDonald ML, Cho MH, Wan ES, Castaldi PJ, Hunninghake GM, Marchetti N, Lynch DA, Crapo JD, Lomas DA, Coxson HO, Bakke PS, lverman EK, Hersh CP; COPDGene and ECLIPSE Investigators. 263 collaborators incl. Kosnik M
DNAH5 is associated with total lung capacity in chronic obstructive pulmonary disease.
Respir Res. 2014 Aug 20;15:97.3,382
JRC IF = 3,092

Cvan Trobec K, Palus S, Tschirner A, von Haehling S, Doehner W, Lainscak M, Anker SD, Springer J.
Rosiglitazone reduces body wasting and improves survival in a rat model of cancer cachexia.
Nutrition. 2014 Sep;30(9):1069-75.
JRC IF = 2,926

Cvan Trobec K, Trontelj J, Springer J, Lainscak M, Kerec Kos M.
Liquid chromatography-tandem mass spectrometry method for simultaneous quantification of bisoprolol, ramiprilat, propranolol and midazolam in rat dried blood spots.
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 May 1;958:29-35.
JRC IF = 2,729

Lainscak M, Farkas J, Frantal S, Singer P, Bauer P, Hiesmayr M, Schindler K.
Self-rated health, nutritional intake and mortality in adult hospitalized patients.
Eur J Clin Invest. 2014 Sep;44(9):813-24.
JRC IF = 2,734

Zupanic E, Zivanovic I, Kalisnik JM, Avbelj V, Lainscak M.
The effect of 4-week rehabilitation on heart rate variability and QTc interval in patients with chronic obstructive pulmonary disease.
COPD. 2014 Dec;11(6):659-69.
JRC IF = 2,673

De Waele J, Lipman J, Sakr Y, Marshall JC, Vanhems P, Barrera Groba C, Leone M, Vincent JL; EPIC II Investigators. 1234 collaborators incl. Tomic V.
Abdominal infections in the intensive care unit: characteristics, treatment and determinants of outcome.
BMC Infect Dis. 2014 Jul 29;14:420.
JRC IF = 2,613

van der Werf MJ, Ködmön C, Katalinić-Janković V, Kummik T, Soini H, Richter E, Papaventsis D, Tortoli E, Perrin M, van Soolingen D, Zolnir-Dovč M, Ostergaard Thomsen V.
Inventory study of non-tuberculous mycobacteria in the European Union.
BMC Infect Dis. 2014 Feb 6;14:62
JRC IF = 2,613

Hersh CP, Make BJ, Lynch DA, Barr RG, Bowler RP, Calverley PM, Castaldi PJ, Cho MH, Coxson HO, DeMeo DL, Foreman MG, Han MK, Harshfield BJ, Hokanson JE, Lutz S, Ramsdell JW, Regan EA, Rennard SI, Schroeder JD, Sciurba FC, Steiner RM, Tal-Singer R, van Beek E Jr, Silverman EK, Crapo JD; COPDGene and ECLIPSE Investigators. 245 collaborators incl. Kosnik M.
Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus.
BMC Pulm Med. 2014 Oct 24;14:164.
JRC IF = 2,404

Cardoso F, Costa A, Norton L, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Biganzoli L, Blackwell KL, Cardoso MJ, Cufer T, El Saghir N, Fallowfield L, Fenech D, Francis P, Gelmon K, Giordano SH, Gligorov J, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Krop I, Kyriakides S, Lin UN, Mayer M, Merjaver SD, Nordström EB, Pagani O, Partridge A, Penault-Llorca F, Piccart MJ, Rugo H, Sledge G, Thomssen C, Van't Veer L, Vorobiof D, Vrieling C, West N, Xu B, Winer E.
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).
Breast. 2014 Oct;23(5):489-502.
JRC IF = 2,381

Cufer T, Knez L.
Update on systemic therapy of advanced non-small-cell lung cancer.
Expert Rev Anticancer Ther. 2014 Oct;14(10):1189-203.
JRC IF = 2,249

Seruga B, Zadnik V, Kuhar CG, Marinko T, Cufer T, Zakotnik B, Zorman D, Ocana A, Amir E.
Association of aromatase inhibitors with coronary heart disease in women with early breast cancer.
Cancer Invest. 2014 May;32(4):99-104.
JRC IF = 2,218

Tomic V, Dowzicky MJ.
Regional and global antimicrobial susceptibility among isolates of Streptococcus pneumoniae and Haemophilus influenzae collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) from 2009 to 2012 and comparison with previous years of T.E.S.T. (2004-2008).
Annals of Clinical Microbiology and Antimicrobials. 2014, 13:52
JRC IF = 2.189

Lainscak M, Letonja M, Kovacic D, Hodoscek LM, Marolt A, Bartolic CM, Mulej M, Penko M, Poles J, Ravnikar T, Iskra MS, Pusnik CS, Jug B.
General public awareness of heart failure: results of questionnaire survey during Heart Failure Awareness Day 2011.
Arch Med Sci. 2014 May 12;10(2):355-60.
JRC IF = 2,030

Roblek T, Trobec K, Mrhar A, Lainscak M.
Potential drug-drug interactions in hospitalized patients with chronic heart failure and chronic obstructive pulmonary disease.
Arch Med Sci. 2014 Oct 27;10(5):920-32.
JRC IF = 2,030

Rozman A, Camlek L, Kern I, Malovrh MM.
Semirigid thoracoscopy: an effective method for diagnosing pleural malignancies.
Radiol Oncol. 2014 Jan 22;48(1):67-71.
JRC IF = 1,912

Stanic K, Zwitter M, Hitij NT, Kern I, Sadikov A, Cufer T.
Brain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survival.
Radiol Oncol. 2014 Apr 25;48(2):173-83.
JRC IF = 1,912

Zwitter M, Stanic K, Rajer M, Kern I, Vrankar M, Edelbaher N, Kovac V.
Intercalated chemotherapy and erlotinib for advanced NSCLC: high proportion of complete remissions and prolonged progression-free survival among patients with EGFR activating mutations.
Radiol Oncol. 2014 Nov 5;48(4):361-8.
JRC IF = 1,912

Eržen B, Šilar M, Šabovič M.
Stable phase post-MI patients have elevated VEGF levels correlated with inflammation markers, but not with atherosclerotic burden.
BMC Cardiovasc Disord. 2014 Nov 22;14:166.
JRC IF = 1,878

Dirkse D, Lamont L, Li Y, Simonič A, Bebb G, Giese-Davis J.
Shame, guilt, and communication in lung cancer patients and their partners.
Curr Oncol. 2014 Oct;21(5):e718-22.
JRC IF = 1,785

Clini EM, Boschetto P, Lainscak M, Janssens W.
Comorbidities in chronic obstructive pulmonary disease from assessment to treatment.
BioMed Research International. 2014. http://dx.doi.org/10.1155/2014/414928
JRC IF = 1,579

Rozman A, Camlek L, Marc-Malovrh M, Kern I, Schönfeld N.
Feasibility and safety of parietal pleural cryobiopsy during semirigid thoracoscopy.
Clin Respir J. 2014 Dec 16
JRC IF = 1,512

Apostolovic S, Stanojevic D, Lainscak M, Gelbrich G, Jankovic-Tomasevic R, Pavlovic M, Djordjevic-Radojkovic D, Salinger-Martinovic S, Putnikovic B, Radovanovic S, Waagstein F, Tomasevic M, Tahirovic E, Inkrot S, Musial-Bright L, Düngen HD.
Regional differences among female patients with heart failure from the Cardiac Insufficiency BIsoprolol Study in ELDerly (CIBIS-ELD).
Cardiol J. 2014;21(3):265-72.
JRC IF = 1,062


2013

Cohen AT, Spiro TE, Büller HR, Haskell L, Hu D, Hull R, Mebazaa A, Merli G, Schellong S, Spyropoulos AC, Tapson V; MAGELLAN Investigators. (collaborators incl. Flezar M)
Rivaroxaban for thromboprophylaxis in acutely ill medical patients.
N Engl J Med. 2013 Feb 7;368(6):513-23.
JRC IF = 54,42

Comin-Colet J, Lainscak M, Dickstein K, Filippatos GS, Johnson P, Lüscher TF, Mori C, Willenheimer R, Ponikowski P, Anker SD.
The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study.
Eur Heart J. 2013 Jan;34(1):30-8.
JRC IF = 14.723

Cheng DT, Kim DK, Cockayne DA, Belousov A, Bitter H, Cho MH, Duvoix A, Edwards LD, Lomas DA, Miller BE, Reynaert N, Tal-Singer R, Wouters EF, Agustí A, Fabbri LM, Rames A, Visvanathan S, Rennard SI, Jones P, Parmar H, MacNee W, Wolff G, Silverman EK, Mayer RJ, Pillai SG; TESRA and ECLIPSE Investigators. 138 collaborators incl. Košnik M
Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2013 Oct 15;188(8):948-57.
JRC IF = 11,986

Farkas J, von Haehling S, Kalantar-Zadeh K, Morley JE, Anker SD, Lainscak M.
Cachexia as a major public health problem : frequent, costly, and deadly.
J Cachexia Sarcopenia Muscle. 2013 Sep;4(3):173-8.
JRC IF = 7,413

Agusti A, Edwards LD, Celli B, Macnee W, Calverley PM, Müllerova H, Lomas DA, Wouters E, Bakke P, Rennard S, Crim C, Miller BE, Coxson HO, Yates JC, Tal-Singer R, Vestbo J; ECLIPSE Investigators. 46 collaborators incl. Kosnik M.
Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort.
Eur Respir J. 2013 Sep;42(3):636-46.
JRC IF = 7,125

Romme EA, Murchison JT, Edwards LD, van Beek E Jr, Murchison DM, Rutten EP, Smeenk FW, Williams MC, Wouters EF, MacNee W; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Study Investigators. 66 collaborators incl. Kosnik M.
CT-measured bone attenuation in patients with chronic obstructive pulmonary disease: relation to clinical features and outcomes.
J Bone Miner Res. 2013 Jun;28(6):1369-77.
JRC IF = 6,589

Maggioni AP, Anker SD, Dahlström U, Filippatos G, Ponikowski P, Zannad F, Amir O, Chioncel O, Leiro MC, Drozdz J, Erglis A, Fazlibegovic E, Fonseca C, Fruhwald F, Gatzov P, Goncalvesova E, Hassanein M, Hradec J, Kavoliuniene A, Lainscak M, Logeart D, Merkely B, Metra M, Persson H, Seferovic P, Temizhan A, Tousoulis D, Tavazzi L; Heart Failure Association of the ESC.
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry.
Eur J Heart Fail. 2013 Oct;15(10):1173-84.
JRC IF = 6,577

Seferovic PM, Stoerk S, Filippatos G, Mareev V, Kavoliuniene A, Ristic AD, Ponikowski P, McMurray J, Maggioni A, Ruschitzka F, van Veldhuisen DJ, Coats A, Piepoli M, McDonagh T, Riley J, Hoes A, Pieske B, Dobric M, Papp Z, Mebazaa A, Parissis J, Ben Gal T, Vinereanu D, Brito D, Altenberger J, Gatzov P, Milinkovic I, Hradec J, Trochu JN, Amir O, Moura B, Lainscak M, Comin J, Wikström G, Anker S; Committee of National Heart Failure Societies or Working Groups of the Heart Failure Association of the European Society of Cardiology.
Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups.
Eur J Heart Fail. 2013 Sep;15(9):947-59.
JRC IF = 6,577

Tavazzi L, Swedberg K, Komajda M, Böhm M, Borer JS, Lainscak M, Ford F, on behalf of the SHIFT Investigators.
Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: insights from the SHIFT study.
Eur J Heart Fail. 2013 Nov;15(11):1296-303.
JRC IF = 6,577

Lainščak M, Anker SD, Haehling S.
No train, no gain: Does this apply to heart failure with preserved ejection fraction?.
Int J Cardiol. 2013 Jan 10;162(2):69-70.
JRC IF = 6,175

Lainscak M, Farkas J, Inkrot S, Gelbrich G, Neskovic AN, Rau T, Tahirovic E, Töpper A, Apostolovic S, Haverkamp W, Herrmann-Lingen C, Anker SD, Düngen HD.
Self-rated health predicts adverse events during β-blocker treatment: the CIBIS-ELD randomised trial analysis.
Int J Cardiol. 2013 Feb 10;163(1):87-92.
JRC IF = 6,175

Tavazzi L, Swedberg K, Komajda M, Böhm M, Borer JS, Lainscak M, Robertson M, Ford I; SHIFT Investigators.
Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study.
Int J Cardiol. 2013 Dec 10;170(2):182-8.
JRC IF = 6,175

Lopert A, Rijavec M, Žavbi M, Korošec P, Fležar M.
Asthma treatment outcome in adults is associated with rs9910408 in TBX21 gene.
Sci Rep. 2013 Oct 10;3:2915.
JRC IF = 5,078

Cufer T, O'Brien ME.
The PARAMOUNT study and the re-challenge chemotherapy issue in advanced non-small cell lung cancer.
Eur J Cancer. 2013 Jun;49(9):2269-2270.
JRC IF = 4,819

Čufer T, Ovčariček T, O'Brien MER.
Systemic therapy of advanced non-small cell lung cancer: Major-developments of the last 5-years.
Eur J Cancer 2013; 49: 1216–1225.
JRC IF = 4,819

Harbeck N, Schmitt M, Meisner C, Friedel C, Untch M, Schmidt M, Sweep CG, Lisboa BW, Lux MP, Beck T, Hasmüller S, Kiechle M, Jänicke F, Thomssen C; Chemo-N 0 Study Group. 45 collaborators incl. Cufer T.
Ten-year analysis of the prospective multicentre Chemo-N0 trial validates American Society of Clinical Oncology (ASCO)-recommended biomarkers uPA and PAI-1 for therapy decision making in node-negative breast cancer patients.
Eur J Cancer. 2013 May;49(8):1825-35.
JRC IF = 4,819

O'Brien ME, Gaafar RM, Popat S, Grossi F, Price A, Talbot DC, Čufer T, Ottensmeier C, Danson S, Pallis A, Hasan B, Van Meerbeeck JP, Baas P.
Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052).
Eur J Cancer. 2013 Sep;49(13):2815-22.
JRC IF = 4,819

Lainščak M, Kadivec S, Košnik M, Benedik B, Bratkovič M, Jakhel T, Marčun R, Mikloša P, Štalc B, Farkaš J.
Discharge Coordinator Intervention Prevents Hospitalizations in Patients With COPD: A Randomized Controlled Trial.
J Am Med Dir Assoc. 2013 Jun;14(6):450.e1-6.
JRC IF = 4,781

Lainscak M, Gosker HR, Schols AM.
Chronic obstructive pulmonary disease patient journey: hospitalizations as window of opportunity for extra-pulmonary intervention.
Curr Opin Clin Nutr Metab Care. 2013 May;16(3):278-83.
JRC IF = 3,972

Auersperger I, Škof B, Leskošek B, Knap B, Jerin A, Lainscak M.
Exercise-induced changes in iron status and hepcidin response in female runners.
PLoS One. 2013;8(3):e58090.
JRC IF = 3,534

Rijavec M, Korošec P, Šilar M, Zidarn M, Miljković J, Košnik M.
Hereditary Angioedema Nationwide Study in Slovenia Reveals Four Novel Mutations in SERPING1 Gene.
PLoS ONE 2013 Feb;8(2):1-6.
JRC IF = 3,534

Trobec K, Kos MK, von Haehling S, Springer J, Anker SD, Lainscak M.
Pharmacokinetics of Drugs in Cachectic Patients: A Systematic Review.
PLoS One. 2013 Nov 8;8(11):e79603.
JRC IF = 3,534

Ebner N, Springer J, Kalantar-Zadeh K, Lainscak M, Doehner W, Anker SD, von Haehling S
Mechanism and novel therapeutic approaches to wasting in chronic disease.
Maturitas. 2013 Jul;75(3):199-206.
JRC IF = 2,861

Lin NU, Thomssen C, Cardoso F, Cameron D, Čufer T, Fallowfield L, Francis PA, Kyriakides S, Pagani O, Senkus E, Costa A, Winer EP;
ESO-MBC Task Force.
International guidelines for management of metastatic breast cancer (MBC) from the European School of Oncology (ESO)-MBC Task Force:
Surveillance, staging, and evaluation of patients with early-stage and metastatic breast cancer.
Breast. 2013 Jun;22(3):203-10.
JRC IF = 2,581

Loncar G, Bozic B, von Haehling S, Düngen HD, Prodanovic N, Lainscak M, Arandjelovic A, Dimkovic S, Radojicic Z, Popovic V.
Association of adiponectin with peripheral muscle status in elderly patients with heart failure.
Eur J Intern Med. 2013 Dec;8(24):818-23.
JRC IF = 2,3


2012

COPDGene Investigators; ECLIPSE Study Investigators, Wells JM, Washko GR, Han MK, Abbas N, Nath H, Mamary AJ, Regan E, Bailey WC, Martinez FJ, Westfall E, Beaty TH, Curran-Everett D, Curtis JL, Hokanson JE, Lynch DA, Make BJ, Crapo JD, Silverman EK, Bowler RP, Dransfield MT;. 199 investigators incl. Košnik M.
Pulmonary arterial enlargement and acute exacerbations of COPD.
N Engl J Med. 2012 Sep;367(10):913-21.
JRC IF = 51,658

Bousquet J, Schünemann HJ, Samolinski B, Zidarn M, et al.; World Health Organization Collaborating Center for Asthma and Rhinitis.
Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs.
J Allergy Clin Immunol. 2012;130(5):1049-62.
JRC IF = 12,047

Korošec P, Košnik M.
Reply : to the editor.
J Allergy Clin Immunol. 2012 Jul;130(1):278-279.
JCR IF = 12,047

Korošec P, Šilar M, Zidarn M, Košnik M.
Reply.
J Allergy Clin Immunol. 2012 Sep;130(3):818-9.
JCR IF = 12,047

Korošec P, Valenta R, Mittermann I, Čelesnik N, Šilar M, Zidarn M, Košnik M.
High sensitivity of CAP-FEIA rVes v 5 and rVes v 1 for diagnosis of Vespula venom allergy.
J Allergy Clin Immunol. 2012;129(5):1406-8.
JCR IF = 12,047

Marolt D, Campos IM, Bhumiratana S, Koren A, Petridis P, Zhang G, Spitalnik PF, Grayson WL, Vunjak-Novakovic G.
Engineering bone tissue from human embryonic stem cells.
PNAS. 2012 May;109(22):8705-9.
JCR IF = 9,737

Cho MH, Castaldi PJ, Wan ES, et al; ICGN Investigators; ECLIPSE Investigators; COPDGene Investigators. 228 investigators, incl. Košnik M.
A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13.
Hum Mol Genet. 2012 Feb 15;21(4):947-57.
JCR IF = 7,692

Lainscak M, von Haehling S, Doehner W, Anker SD.
The obesity paradox in chronic disease : facts and numbers.
J Cachexia Sarcopenia Muscle. 2012 Mar;3(1):1-4.
JCR IF = 7,413

Rau T, Düngen HD, Edelmann F, Waagstein F, Lainščak M, Dimković S, Apostolović S, Nešković AN, Haverkamp W, Gelbrich G, Eschenhagen T.
Impact of the β1-Adrenoceptor Arg389Gly Polymorphism on Heart-Rate Responses to Bisoprolol and Carvedilol in Heart-Failure Patients.
Clin Pharmacol Ther. 2012 Jul;92(1):21-8.
JCR IF = 6,846

Sersa G, Cufer T, Paulin SM, Cemazar M, Snoj M.
Electrochemotherapy of chest wall breast cancer recurrence.
Cancer Treat Rev. 2012 Aug;38(5):379-86.
JCR IF = 6,024

Celesnik N, Vesel T, Rijavec M, Silar M, Eržen R, Košnik M, Kloft Žitnik SE, Avčin T, Korošec P.
Short-term venom immunotherapy induces desensitization of FcεRI-mediated basophil response.
Allergy. 2012;67(12):1594-600.
JRC IF = 5,883

Eržen R, Košnik M, Šilar M, Korošec P.
Basophil response and the induction of a tolerance in venom immunotherapy: a long-term sting challenge study.
Allergy. 2012;67(6):822-30.
JRC IF = 5,883

Kopac P, Rudin M, Gentinetta T, Gerber R, Pichler Ch, Hausmann O, Schnyder B, Pichler WJ.
Continuous apple consumption induces oral tolerance in birch-pollen-associatedapple allergy.
Allergy. 2012 Feb;67(2):280-5.
JRC IF = 5,883

Doehner W, Todorovic J, Kennecke C, Rauchhaus M, Sandek A, Lainscak M, van Linthout S, Tschöpe C, von Haehling S, Anker SD.
Improved insulin sensitivity by the angiotensin receptor antagonist irbesartan in patients with systolic heart failure: A randomized double-blinded placebo-controlled study.
Int J Cardiol. 2012;161(3):137-42.
JRC IF = 5,509

Gelbrich G, Edelmann F, Inkrot S, Lainscak M, Apostolovic S, Neskovic AN, Waagstein F, Loeffler M, Anker SD, Dietz R, Düngen HD; CIBIS-ELD investigators.
Is target dose the treatment target? Uptitrating beta-blockers for heart failure in the elderly.
Int J Cardiol. 2012 Feb 23;155(1):160-6.
JCR IF = 5,509

Marcun R, Sustic A, Brguljan PM, Kadivec S, Farkas J, Kosnik M, Coats AJ, Anker SD, Lainscak M.
Cardiac biomarkers predict outcome after hospitalisation for an acute exacerbation of chronic obstructive.
Int J Cardiol. 2012 Nov 29;161(3):156-9.
JCR IF = 5,509

Meyer P, Desai RV, Mujib M, Feller MA, Adamopoulos C, Banach M, Lainscak M, Aban I, White M, Aronow WS, Deedwania P, Iskandrian AE, Ahmed A.
Right ventricular ejection fraction 20% is an independent predictor of mortality but not of hospitalization in older systolic heart failure patients.
Int J Cardiol. 2012 Feb 23;155(1):120-5.
JCR IF = 5,509

Stankovic I, Neskovic AN, Putnikovic B, Apostolovic S, Lainscak M, Edelmann F, Doehner W, Gelbrich G, Inkrot S, Rau T, Herrmann-Lingen c, Anker SD, Düngen HD.
Sinus rhythm versus atrial fibrillation in elderly patients with chronic heart failure — Insight from the Cardiac Insufficiency Bisoprolol Study in Elderly.
Int J Cardiol. 2012 Nov 29;161(3):160-5.
JCR IF = 5,509

Spruit MA, Polkey MI, Celli B, Edwards LD, Watkins ML, Pinto-Plata V, Vestbo J, Calverley PM, Tal-Singer R, Agusti A, Coxson HO, Lomas DA, MacNee W, Rennard S, Silverman EK, Crim CC, Yates J, Wouters EF; Evaluation of COPD Longitudinally to Identify P redictive Surrogate Endpoints (ECLIPSE) study investigators. 65 investigators inc. Košnik M.
Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease.
J Am Med Dir Assoc. 2012 Mar;13(3):291-7.
JCR IF = 5,302

Sodja E, Knez L, Kern I, Ovčariček T, Sadikov A, Cufer T.
Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy.
Eur J Cancer. 2012 Dec;48(18):3378-85.
JCR IF = 5,061

Ribi K, Aldridge J, Phillips KA, Thompson A, Harvey V, Thürlimann B, Cardoso F, Pagani O, Coates AS, Goldhirsch A, Price KN, Gelber RD, Bernhard J; BIG 1-98 Collaborative Group; International Breast Cancer Study Group. 276 investigators incl. Cufer T.
Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer.
Br J Cancer. 2012 May 8;106(10):1618-25.
JCR IF = 5,082

Zidarn M, Košnik M, Šilar M, Grahek A, Korošec P.
Rhinitis symptoms caused by grass pollen are associated with elevated basophile allergen sensitivity
and a larger grass-specific immunoglobulin E fraction.
Clin Exp Allergy 2012;(42)1:49-57.
JCR IF = 4,789

de Beer JL, Kremer K, Ködmön C, Supply P, van Soolingen D, and the Global Network for the Molecular Surveillance of Tuberculosis 2009. 37 collaborators incl. Stojkovic-Bidovec U.
First worldwide proficiency study on variable-number tandem-repeat typing of Mycobacterium tuberculosis complex strains.
J Clin Microbiol. 2012 Mar;50(3):662-9.
JCR IF = 4,068

Trobec K, Knez L, Meško Brguljan P, Cufer T, Lainščak M.
Estimation of renal function in lung cancer patients.
Lung Cancer. 2012 Jun;76(3):397-402.
JCR IF = 3,392

Žitnik SE, Vesel T, Avčin T, Šilar M, Košnik M, Korošec P.
Monitoring honeybee venom immunotherapy in children with the basophil activation test.
Pediatr Allergy Immunol. 2012;(23)2:167-72.
JCR IF = 3,376

Agustí A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R, Miller BE, Vestbo J, Lomas DA, Calverley PM, Wouters E, Crim C, Yates JC, Silverman EK, Coxson HO, Bakke P, Mayer RJ, Celli B; Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators.63 investigators, incl. Košnik M.
Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype.
PLoS One. 2012;7(5):e37483.
JCR IF = 3,73

Jusufović E, Rijavec M, Keser D, Korošec P, Sodja E, Iljazović E, Radojević Z, Košnik M.
Let-7b and miR-126 Are Down-Regulated in Tumor Tissue and Correlate with Microvessel Density and Survival
Outcomes in Non–Small–Cell Lung Cancer.
PLoS ONE. 2012;7(9): e45577.
JCR IF = 3,73

Grassi L, Watson M, and on behalf of the IPOS Federation of Psycho-Oncology Societies’ co-authors; 31 co-authors, incl. Simonič A.
Psychosocial care in cancer: an overview of psychosocial programmes and national cancer plans of countries within the International Federation of Psycho-Oncology Societies.
Psycho-Oncology. 2012;21:1027–33.
JRC IF = 3,506

Povšič K, Fležar M, Možina J, Jezeršek M.
Laser 3-D measuring system and real-time visual feedback for teaching and correcting breathing.
J Biomed Opt. 2012 Mar;17(3):036004.
JCR IF = 2,881

Loncar G, von Haehling S, Tahirovic E, Inkrot S, Mende M, Sekularac N, Lainscak M, Apostolovic S, Putnikovic B, Edelmann F, Wachter R, Dimkovic S, Waagstein F, Gelbrich G, Düngen HD.
Effect of beta blockade on natriuretic peptides and copeptin in elderly patients with heart failure and preserved or reduced ejection fraction: results from the CIBIS-ELD trial.
Clin Biochem. 2012 Jan;45(1-2):117-22.
JCR IF = 2,45


2011

Breast Cancer International Research Group, Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay MA, Riva A, Crown J; Breast Cancer International Research Group. 400 collaborators, incl. Cufer T.
Adjuvant trastuzumab in HER2-positive breast cancer.
N Engl J Med. 2011 Oct 6;365(14):1273-83.
JCR IF = 53,298

Vogelmeier C, Hederer B, Glaab T, Schmidt H, Rutten-van Mölken M P.M.H., Beeh KM, Rabe KF, Fabbri LM, for the POET-COPD Investigators incl. Fležar M.
Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD.
N Engl J Med 2011;364(12):1093-1103
JCR IF = 53,298

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, Cutter D, Davies C, Ewertz M, Godwin J, Gray R, Pierce L, Whelan T, Wang Y, Peto R. 690 collaborators incl. Cufer T.
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.
Lancet. 2011 Nov 12;378(9804):1707-16.
JCR IF = 38,278

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Davies C, Godwin J, Gray R, Clarke M, Cutter D, Darby S, McGale P, Pan HC, Taylor C, Wang YC, Dowsett M, Ingle J, Peto R. 693 collaborators incl. Cufer T.
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.
Lancet. 2011 Aug 27;378(9793):771-84.
JCR IF (2010)= 38,278

Bonnefoi H, Piccart M, Bogaerts J, Mauriac L, Fumoleau P, Brain E, Petit T, Rouanet P, Jassem J, Blot E, Zaman K, Cufer T, Lortholary A, Lidbrink E, André S, Litière S, Lago LD, Becette V, Cameron DA, Bergh J, Iggo R; EORTC 10994/BIG 1-00 Study Investigators.
TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial.
Lancet Oncol. 2011 Jun;12(6):527-39.
JCR IF = 22,589

Regan MM, Neven P, Giobbie-Hurder A, Goldhirsch A, Ejlertsen B, Mauriac L, Forbes JF, Smith I, Láng I, Wardley A, Rabaglio M, Price KN, Gelber RD, Coates AS, Thürlimann B; BIG 1-98 Collaborative Group; International Breast Cancer Study Group (IBCSG). 885 collaborators incl. Cufer T.
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8•1 years median follow-up.
Lancet Oncol. 2011 Nov;12(12):1101-8.
JCR IF = 22,589

Korošec P, Valenta R, Mittermann I, Čelesnik N, Eržen R, Zidarn M, Košnik M.
Low sensitivity of commercially available rApi m 1 for diagnosis of honeybee venom allergy.
J Allergy Clin Immunol 2011 Sep;128(3):671-3.
JCR IF = 11,003

Sin DD, Miller BE, Duvoix A, Man SF, Zhang X, Silverman EK, Connett JE, Anthonisen NA, Wise RA, Tashkin D, Celli BR, Edwards LD, Locantore N, Macnee W, Tal-Singer R, Lomas DA; ECLIPSE Investigators. 67 collaborators incl. Košnik M.
Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2011 May 1;183(9):1187-92.
JCR IF = 11,08

Lainscak M, von Haehling S, Doehner W, Sarc I, Jeric T, Ziherl K, Kosnik M, Anker SD, Suskovic S.
Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease.
J Cachexia Sarcopenia Muscle. 2011 Jun;2(2):81-86.
JCR IF(2013) = 7,413

Trobec K, von Haehling S, Anker SD, Lainscak M.
Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexia. J Cachexia Sarcopenia Muscle. 2011 Dec;2(4):191-200.
JCR IF(2013) = 7,413
Ahmed MI, Lainscak M, Mujib M, Love TE, Aban I, Piña IL, Aronow WS, Bittner V, Ahmed A.
Gender-related dissociation in outcomes in chronic heart failure: Reduced mortality but similar hospitalization in women.
Int J Cardiol. 2011 Apr 1;148(1):36-42.
JCR IF = 7,078

Doehner W, Todorovic J, Kennecke C, Rauchhaus M, Sandek A,Lainscak M, van Linthout S, Tschöpe C, von Haehling S, Anker SD.
Improved insulin sensitivity by the angiotensin receptor antagonist irbesartan in patients with systolic heart failure: A randomized double-blinded placebo-controlled study.
Int J Cardiol. 2012 Nov 29;161(3):137-42.
JCR IF = 7,078

Siedlinski M, Cho MH, Bakke P, Gulsvik A, Lomas DA, Anderson W, Kong X, Rennard SI, Beaty TH, Hokanson JE, Crapo JD, Silverman EK; COPDGene Investigators; ECLIPSE Investigators. 216 collaborators, incl. Košnik M.
Genome-wide association study of smoking behaviours in patients with COPD.
Thorax. 2011 Oct;66(10):894-902. Epub 2011 Jun 16.
JCR IF = 6,84

Szabo T, von Haehling S, Habedank D, Rauchhaus M, Lainscak M, Sandek A, Schefold J, Anker SD, Doehner W.
Usefulness of minimal modelling to assess impaired insulin sensitivity in patients with chronic heart failure.
Int J Cardiol 2011; 147 (1): 47-51
JCR IF (2010)= 6,802

Kett DH, Azoulay E, Echeverria PM, Vincent JL; Extended Prevalence of Infection in ICU Study (EPIC II) Group of Investigators. 1232 collaborators incl.Tomič V.
Candida bloodstream infections in intensive care units : analysis of the extended prevalence of infection in intensive care unit study.
Crit Care Med. 2011 Apr;39(4):665-70.
JCR IF = 6,33

von Minckwitz G, Schwedler K, Schmidt M, Barinoff J, Mundhenke C, Cufer T, Maartense E, de Jongh FE, Baumann KH, Bischoff J, Harbeck N, Lück HJ, Maass N, Zielinski C, Andersson M, Stein RC, Nekljudova V, Loibl S; GBG 26/BIG 03-05 study group and participating investigators.
Trastuzumab beyond progression : overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer.
Eur J Cancer. 2011 Oct;47(15):2273-81.
JCR IF = 5,536

Regan MM, Price KN, Giobbie-Hurder A, Thürlimann B, Gelber RD; International Breast Cancer Study Group and BIG 1-98 Collaborative Group - in total 514 collaborators incl. Cufer T.
Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenoausal women with hormone receptor-positive, early breast cancer.
Breast Cancer Res. 2011 May 26;13(3):209.
JCR IF = 5,245

Cizman M; Slovenian Consumption Study Group. 37 collaborators incl. Jošt M.
Nationwide hospital antibiotic consumption in Slovenia.
J. Antimicrob. Chemother. 2011;66(9): 2189-2191.
JCR IF = 5,068

Düngen HD, Apostolovic S, Inkrot S, Tahirovic E, Töpper A, Mehrhof F, Prettin C, Putnikovic B, Neskovic AN, Krotin M, Sakac D, Lainščak M, Edelmann F, Wachter R, Rau T, Eschenhagen T, Doehner W, Anker SD, Waagstein F, Herrmann-Lingen C,Gelbrich G, Dietz R
Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial
Eur J Heart Fail. 2011 Jun;13(6):670-80.
JCR IF = 4,896

Lainščak M, Blue L, Clark AL, Dahlström U, Dickstein K, Ekman I, McDonagh T, McMurray JJ, Ryder M, Stewart S, Strömberg A, Jaarsma T.
Self-care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology.
Eur J Heart Fail. 2011 Feb;13(2):115-26.
JCR IF = 4,896

McDonagh TA, Blue L, Clark AL, Dahlström U, Ekman I, Lainščak M, McDonald K, Ryder M, Strömberg A, Jaarsma T
European Society of Cardiology Heart Failure Association Standards for delivering heart failure care.
Eur J Heart Fail 2011; 13: 235–241.
JCR IF = 4,896

Wei Y, Cui C, Lainščak M, Zhang X, Li J, Huang J, Zhang H, Zheng Z, Hu S.
Type-specific dysregulation of matrix metalloproteinases and their tissue inhibitors in end-stage heart failure patients: relationship between MMP-10 and LV remodelling.
J Cell Mol Med. 2011 Apr;15(4):773-82
JCR IF = 4,125

Budič M, Rijavec M, Petkovšek Z, Zgur-Bertok D.
Escherichia coli Bacteriocins: Antimicrobial Efficacy and Prevalence among Isolates from Patients with Bacteraemia.
PLoS One. 2011;6(12):e28769.
JCR IF = 4,092

Šmerc A,Sodja E, Legiša M.
Posttranslational modification of 6-phosphofructo-1-kinase as an important feature of cancer metabolism.
PLoS One. 2011 May;6(5):e19645.
JCR IF = 4,092

Qiu W, Cho MH, Riley JH, Anderson WH, Singh D, Bakke P, Gulsvik A, Litonjua AA, Lomas DA, Crapo JD, Beaty TH, Celli BR, Rennard S, Tal-Singer R, Fox SM, Silverman EK, Hersh CP; ECLIPSE Investigators. 66 collaborators incl. Košnik M.
Genetics of sputum gene expression in chronic obstructive pulmonary disease.
PLoS One. 2011;6(9):e24395.
JCR IF = 4,092

Knez L, Sodja E, Kern I, Košnik M, Cufer T.
Predictive value of multidrug resistance proteins, topoisomerases II and ERCC1 in small cell lung cancer: A systematic review.
Lung Cancer. 2011; 72 (3): 271–9.
JCR IF = 3,434

Pate M, Kušar D, Žolnir-Dovč M, Ocepek M.
MIRU-VNTR typing of Mycobacterium avium in animals and humans: Heterogeneity of Mycobacterium avium subsp. hominissuis versus homogeneity of Mycobacterium avium subsp. avium strains.
Res Vet Sci. 2011 Dec;91(3):376-81.
JCR IF (2010) = 1,649



Raziskovalna dejavnost
» Organizacija raziskovalne dejavnosti
» Raziskovalci KOPA Golnik
» Mladi raziskovalci
» Raziskovalni projekti
» Raziskovalni projekti na MVZT
» Pomembnejše objave
» Knjižnica
» Raziskovalna oprema